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Abstract 
TAR DNA Binding protein (TDP-43) is a member of the heterogeneous nuclear 
ribonucleoprotein family with crucial splicing, transport and regulatory function of 
genetic material inside mammalian cells. Unfortunately, TDP-43 positive 
cytoplasmic aggregates occurring with post-translational modifications are a 
common hallmark in neurodegenerative diseases observed in Alzheimer’s, 
Parkinson’s, amyotrophic lateral sclerosis (ALS) and fronto-temporal lobar 
degeneration (FTLD) diseases. Mutations in the TARDBP gene responsible for 
encoding TDP-43, have been directly correlated with onset of ALS and FLTD. Disease 
models describing TDP-43 proteinopathy suggests onset may derive through either 
cytoplasmic mis-localisation or a loss of nuclear function but it is unclear if or how 
disease associated point-mutations contribute to these observations. In order to 
determine the effects these mutations have on the protein, a fragment containing 
the tandem RRM domains (residues 101-265), responsible for the proteins nucleic 
acid binding function was tested. Using small angle X-ray scattering, circular 
dichroism, isothermal titration calorimetry and thermal assay methodology it was 
demonstrated that initial structures of all variants are similar but mutations (D169G 
and K263E) confer resistance to thermal denaturation by up to 4.9 ± 0.6˚C.  This 
stability positively correlated with an increase in half-life when tested in the full-
length variant using a neuron cell model suggesting that protein turn-over is a 
contributing disease factor.   
This study was also concerned with solving an X-ray crystallographic DNA binding 
complex structure for E.coli DPS and mapping interactions with neighbouring DPS 
complexes. These mechanisms are important in DPS function to protect nucleic 
acids during prokaryote stress. DPS is conserved in almost all prokaryotes however 
not all species can interact with DNA. Using X-ray crystallography, a model of E.coli 
DPS was built to 2.8 Å resolution from DNA containing samples showing both DNA 
and N-terminal residues were absent. Stabilising polar interactions were shown to 
form between neighbouring dodecamer structures involving T12, R18, D20, N99, 
S100, S106 and K134. Polar contacts are observed in all compared crystallographic 
structures from different species but the residues involved are poorly conserved, 
despite strong similarities between sequence and structure. This suggests that 
these contacts may contribute to stabilising the DNA-DPS complexes but form 
indiscriminately between exposed polar residues available on the dodecamer 
surface. These interactions are likely to contribute to the thermal stability of DNA-
DPS complexes to aid in the proteins protective function.  
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Chapter I  
 
TDP-43 proteinopathy 
 
1.1 TDP-43 proteinopathies 
 
Mis-localised TAR DNA binding protein with a molecular weight of 43 kDa (TDP-43) 
is a common hallmark in many human neurodegenerative diseases. During TDP-43 
related onset, the protein commonly forms cytoplasmic aggregates containing C-
terminal truncates that are post-translationally modified by hyper-phosphorylation 
and ubiquitination in neurons and surrounding glial cells [1,2]. Mutations of the 
TARDBP gene located on the 1p36 locus [3] responsible for encoding TDP-43 have 
been directly associated with onset of amyotrophic lateral sclerosis (ALS) and 
fronto-temporal lobar degeneration (FTLD), both regarded as a spectrum of TDP-43 
proteinopathy [4]. It is not uncommon for both diseases to manifest within the 
same individual to support this classification [5]. 
ALS, also referred to as common motor neuron disease or Lou Gehrig’s disease in 
the United States, is associated with neuronal loss in the spinal cord leading to 
muscle weakness and atrophy [6]. The disease is progressive and initial symptoms 
can include dysarthria, dysphagia, sialorrhoea, dysphonia, limb weakness, cramps 
and paralysis [7]. As the disease progresses,  reduced activity and inability of limb 
movement, loss of speech and ability to swallow lead to a loss of independence and 
reliance on full-time care [8]. Death typically occurs within five years after the onset 
of symptoms for the majority of patients, often from respiratory failure [9]. Around 
10% of ALS is familial (fALS), arising from hereditary phenotypes, whereas the 
remaining 90% is described as sporadic (sALS) with unknown cause [10].  
Similarly, FTLD is characterised by neuronal loss in the brain’s front temporal lobes. 
Symptoms present as behavioural changes, including emotional outbursts, 
progressive non-fluent aphasia and dementia [11]. FTLD accounts for ~20% of pre-
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senile dementia, manifesting between 45-65 years of age and is the second largest 
cause of global dementia after Alzheimer’s disease [12,13]. These diseases differ by 
the level of a patient’s preserved cognitive ability. FTLD patients are likely to retain 
memory, perception, spatial awareness and praxis [13] which are more often 
disrupted during the onset of Alzheimers’. FTLD is progressive and prognosis for 
survival is typically 8 years after onset [13].  There are no effective cures for ALS or 
FTLD, thus, both cause terminal illness. 
TDP-43 aggregates are present in ~95% of ALS, ~50% of FTLD patients and in ~15% 
of patients manifesting both [14]. Globally, the prevalence of ALS is ~4 per 100,000 
individuals [15] where mutations in the TDP-43 gene are associated with ~1.5% 
sALS [16] and 1-5% of fALS [17,18].  TARDBP mutations have an estimated 
prevalence within FTLD patients of 1.9-2.6%, as determined through a small Italian 
patient population of 252 individuals [19]. As a proportion of global dementia 
(estimated as ~4700 per 100,000 [20]) FTLD contributes to ~10-15% of cases, in 
which TDP-43 proteinopathy is present in ~55% known as FTLD with ubiquitinated 
inclusions (FTLD-U) [21]. Considering these high prevalence rates, rare TARDBP 
mutations could affect a significant number of individuals globally to warrant their 
study and expose potential causes for TDP-43 mis-localisation and disease onset.  
TDP-43 inclusions are also present in 20-25% of Alzheimer’s [21] and Parkinson’s 
disease cases [22] suggesting that the cause of onset in some of these cases may 
also derive from TDP-43 dysfunction.      
1.2 TDP-43 function  
 
TDP-43 is ubiquitously expressed in mammalian cell types and is a member of the 
heterogeneous ribonucleoprotein (hnRNP) family which have an integral role in 
manipulating a wide range of nucleic acid targets. The protein is a dimer [22] and 
performs a variety of functions including; splicing [23], transport [24], transcription 
[25,26], translation [27] and stress granule formation [28]. The first role described 
was the inhibition of the transcription of HIV-1 DNA through binding the trans 
active response (TAR) sequence motif [26] for which it is named thereafter. 
Thousands of nucleic acid targets have been predicted to bind TDP-43, including 
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both single and double stranded DNA and RNA ligands. These include the cyclin 
dependent kinase-6 gene [29], the pre mRNA of the cystic fibrosis transmembrane 
conductance regulator [30] and histone deacetylase 6 [31], where TDP-43 has direct 
splicing and regulatory functions.   
In the adult brains of mice, TDP-43 is estimated to bind a third of all mRNA [32] with 
a similar number predicted in humans [33].  Hence TDP-43 is likely to have an 
integral role in the processing of genetic material, exemplified during TDP-43 knock-
down that coincides with developmental defects and shortened life-span of 
eukaryotic organisms including mice [34–36], drosophila [37,38,31] and zebra fish 
[39].  Consequently, removal of TDP-43 in eukaryote models lead to lethal 
phenotypes emphasising the proteins importance during development and normal 
cell function.   
TDP-43 is localised inside the nucleus. However, its natural function as an mRNA 
transporter requires that it fluxes between the cytoplasmic and nuclear 
compartments as an mRNA transport granule [40]. In this role, it is able to co-
localise with fragile X mental retardation protein and staufen-1. These two proteins 
are involved in local translation at synapses in rat hippocampal neurons, specifically 
relating some of TDP-43’s function as a neuronal activity responsive factor  in 
neuronal cells [27].    
The protein is capable of regulating its own expression by binding to the 3’ UTR of 
its mRNA as part of a negative feedback loop [41]. It is postulated that this may be 
important during TDP-43 mediated disease models [42] discussed in the 
subsequent section. During stress TDP-43 can be recruited into stress granules 
[28,43] to protect mRNA which requires cytosolic redistribution from the nucleus 
which can then return once the stress-response is resolved [44,45]. 
1.3 TDP-43 disease models 
 
TDP-43 mediated disease onset has been postulated by two different models: the 
loss or gain of TDP-43 auto-regulation. Both models are based on TDP-43’s ability to 
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inhibit its own protein expression by binding to the 3’ UTR of its mRNA (Figure 1.1) 
[41]. Each model describes TDP-43 cytoplasmic mis-localisation as a feature of 
neurodegeneration but the causes of toxicity are attributed to which cellular 
compartment auto-regulation occurs.   
The ‘loss of autoregulation’ model assumes this function is performed within the 
nucleus where a reduction in nuclear TDP-43 up regulates nuclear expression. Here, 
an unknown stress causes the cytoplasmic mis-localisation of TDP-43, perhaps by 
stress granule recruitment that redistributes the protein from the nucleus which in-
turn up-regulates TDP-43 nuclear expression. If the stress remains, newly 
synthesized protein will accumulate in the cytoplasm in a cycling manner. 
Increasing TDP-43 cytoplasmic concentrations undergo post translational 
modification and form inclusions that exacerbate the stress leading to a gain of 
cyto-toxicity and neuron degeneration.   
Alternatively, TDP-43 is regulated in the cytoplasm as shown in the ‘gain of auto-
regulation’ model (Figure 1.1B). Here elevated cytosolic TDP-43 levels down-
regulate expression. Through an unknown stress, nuclear TDP-43 is again 
redistributed to increase cytosolic concentrations, though initially it cannot regulate 
its mRNA due to participation in other functions e.g. stress granule formation. The 
total TDP-43 concentration is initially increased, however over-time cytoplasmic 
species restore this auto-regulatory function leading to a reduction of newly 
synthesized protein, reduction in nuclear TDP-43 concentrations and a disruption of 
normal TDP-43 nuclear function, that causes neurodegeneration. The removal of 
TDP-43’s nuclear localisation sequence by N-terminal cleavage may worsen the 
effect in this model since truncates cannot relocate back to the nucleus [42].  
Evidence of disease associated mis-localisation is observed in animal models that 
support both ‘auto-regulatory’ models described for TDP-43 proteinopathy. For 
example, increasing levels of cytosolic TDP-43 have been correlated with 
neurodegeneration in primary rat cortical neurons, independent of inclusions and 
nuclear clearance [46], with similar observations in mice  [47]. This exposes TDP-43 
mis-localisation as a key disease feature. The formation of aggregates have been 
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shown to cause toxicity in yeast models [48,49] however symptoms of disease 
without inclusions are observed in neurons of rodent models [50,51] that implies 
aggregation need not be necessary but may increase the severity of toxicity. It is 
worth note that knock-down of TDP-43 leads to developmental defects and a 
reduction in survival in eukaryotic model organisms, to also support a loss of 
normal TDP-43 function as a viable cause of TDP-43 mediated neurotoxicity [31,34–
39]. 
 
Figure 1.1 TDP-43 disease models. A, Loss of auto-regulation model and B, Gain of 
auto-regulation model, adapted from Lee et. al. 2011 [42].  
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1.4 TDP-43 mutations  
 
There are forty identified ALS and FTLD-U disease related mutations situated 
predominately on the C-terminal domain of TDP-43 (Figure 1.2). Only three are 
situated elsewhere: the A90V mutation in the N-terminus, D169G within RNA 
recognition motif (RRM) 1 and K263E situated immediately after RRM2.  At present 
only one C-terminal disease related mutation R361S has been shown to change a 
function of TDP-43, manifesting as an impairment to stress granule formation, 
whilst the D169G mutation had no effect to function [52]. However, other non-
disease related C-terminal mutations have been shown to impair the self-
aggregation potential of TDP-43 through a hydrophobic patch between residues 
318-343. Here two mutations: A324E and M337E could individually reduce TDP-43 
self-aggregation and completely perturb this function in vitro as a double mutation 
[53]. Interestingly, M337 is an ALS disease related locus and therefore the ALS 
associated M377V mutation may be important in the recruitment of TDP-43 into 
stress granules.  
Unfortunately there are a limited amount of published data available exploring the 
relationship between C-terminal mutations and function to accurately determine 
whether mutant mediated disease onset arises through changes to TDP-43 cellular 
activity. Furthermore only 32% of the C-terminal domain has any function assigned, 
limited to residues ranging between 318-366 [53,54] meaning it is still unknown 
whether at least 62% of disease related loci cause a change to function [54] (Figure 
1.3). The annotation of the C-terminal domain is further complicated by additional 
functions, as identified in TDP-43’s interaction with hnRNPA2 mediated by a C-
terminal binding motif that overlaps with the previously described hydrophobic 
patch. This region between residues 321-366 was shown as important in the joint 
splicing function involving hnRNPA2 and TDP-43. In addition, disease related 
mutations: Q331K, M377 and G348C do not perturb this binding or activity [55]. As 
such, there is no typical trend that links TDP-43 C-terminal disease mutations with a 
loss of function due in part by a lack of functional annotation and proportion of 
mutations tested.  
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A growing number of C-terminal domain disease mutations are being identified 
with a tendency to increase cellular longevity in vivo. This has been observed in 
neural and isogenic cell-line models and include a significant number of disease 
related mutants. In Neuro-2A cells a correlation was observed between cellular 
half-life and accelerated disease onset through several of these mutations [56]. 
These included: A315T, Q343R, N352S, G298S, M337V, G348C and A382T. Each 
mutant had a longer half-life than wild-type and a slight tendency to localise into 
the cytoplasm. This is in agreement with disease correlations in primary rat cortical 
neuron models [46].  This finding was also supported by ALS related mutants 
G298S, Q331K and M337V enhancing longevity in isogenic cell-lines and G298S 
even degraded a third slower than wild-type in primary human fibroblast cells [57].  
A number of similar studies conclude that mutant turnover can increase half-life 3-
fold more than wild-type to suggest that cellular mis-localisation and protein 
turnover are important disease determinants.  
Furthermore, mutants that increased cellular stability also positively correlates with 
accelerated disease onset in Neuro-2A cell lines [56].  This implies that TDP-43 
stability could have a direct effect on clinical prognosis. The frequency of mutations 
associated with ALS can be observed in Figure 1.3 adapted from Pesiridis et. al 
2009, looking into ALS mutant frequency in patients [54]. Note that most of these 
mutations are situated on the C-terminal domain, however the most frequent; 
A382T has not been attributed to any change in function.   
 
Figure 1.2 TDP-43 domain dissection and neurodegenerative disease point 
mutations. TDP-43s’ functional domains containing; the N-terminal with the 
nuclear localisation signal (NLS), the RNA recognition motifs (RRM) 1 and 2 with the 
nuclear export signal (NES) and C-terminal. ALS and FTLD-U mutations are situated 
throughout the protein with the majority localised on the C-terminal domain.  
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Figure31.3 Frequency of  TDP-43 ALS disease mutations. Summary of mutation 
frequencies identified in patients with ALS, adapted from Pesiridis et. al. 2009 [54]. 
 
 
1.5 Post-translational modifications 
 
Post-translational modifications associated with TDP-43 inclusions are consistently 
found within the brains and spinal cords of patients [1]. These modifications include 
hyperphosphorylation, ubiquitination and protein cleavage. The truncation of TDP-
43 results in 25 kDa [1,2], 27 kDa [58] and  35 kDa C-terminal fragments [59] found 
with full length within cytosolic inclusions. This has led to the hypothesis that the C-
terminal domain with the aid of the RRM domains mediate the aggregation during 
disease onset [59–61]. Dissection of the C-terminal domain has determined regions 
that readily form amyloid-like fibrils [62] that may be significant in propagating 
disease, similar to seeding in prion mediated neurodegeneration [63].  
Interestingly the ~25 kDa C-terminal fragments lacking RRM1 are readily degraded 
with a half-life of ~4 hours [64] compared to ~12 hours  of full length TDP-43 in 
mammalian cells [57]. This implies that individually these fragments are non-toxic. 
However, when restricting caspase cleavage at D169, responsible for producing 
non-toxic 27 kDa species, neuro-toxic 35 kDa fragments are generated [58] to 
suggest that RRM1 residues have an active involvement in cyto-toxicity in cultured 
neurons. 
20 
 
The fact that full length TDP-43 with aid of the N-terminus can also facilitate 
aggregation [65] and that the N-terminal ALS associated A90V mutation increases 
inclusion formation, suggests that cleavage is not necessary for aggregation [66]. 
However, truncated fragments missing the NLS cannot return to the nucleus and 
may linger in the cytoplasm to enhance recruitment to pre-existing aggregates and 
contribute to their cytotoxicity. Although TDP-43 neurodegeneration is observed 
without inclusions in rodent models [50,51], fragments from inclusions can seed 
aggregation in healthy neurons [63] to provide a convenient explanation to describe 
disease progression and warrants further investigation. 
The observed hyper-phosphorylation associated with TDP-43 proteinopathies 
occurs before ubiquitination [67,68]. This is not required for TDP-43 aggregation, 
truncation or toxicity in cultured cells [69,70]. Notably phosphorylation does 
decrease the turnover of TDP-43, at least for C-terminal fragments in human 
neuroblastoma cells from ~14 to ~22 hours [71]. This is similar to the enhanced 
half-life observed for TDP-43 C-terminal domain disease related mutations [56]. 
This begs the question of whether phosphorylation exacerbates toxicity through 
increasing TDP-43 cellular stability, via a similar mechanism as disease related 
point-mutations. TDP-43 hyper-phosphorylation may also confer a resistance to the 
ubiquitin degradation pathway, employed to remove misfolded protein [71]. This 
hypothesis is supported by rare functional null mutations in the UBQLN2 gene 
responsible for encoding ubiquilin-2, a protein involved in protein degradation that 
is associated to X-linked ALS [72].  
Mutations within TDP-43 have yet to be associated with a modified 
phosphorylation profile to suggest they contribute to disease independently from 
post-translational modification. This is also likely to be true of the ubiquitination of 
TDP-43, which has not been associated with any disease related feature and is 
probably a consequence of degradation resistance.     
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1.6 TDP-43 toxicity: mis-localisation or loss of function ? 
 
Current disease models using auto-regulation to describe disease onset (Figure 1.1) 
suggest that increased levels of cytoplasmic TDP-43 are a common factor in TDP-43 
proteinopathy. The problem is that this observation is consistent through either a 
gain of toxicity associated with elevated cytosolic TDP-43 or as a loss of normal 
nuclear TDP-43 function by two exclusive paths as described in the auto-regulation 
models. Since disease onset is based on the location of auto-regulation, even 
associating cellular longevity with C-terminal mutations doesn’t definitively explain 
how toxicity is mediated.    
In support of a gain in cytosolic toxicity, disease symptoms observed in  rat neurons 
correlated best with levels of mis-localised TDP-43 independent from inclusions or 
normal endogeneous levels of nuclear TDP-43 [46]. This suggests that normal 
nuclear function is still maintained during disease and that mis-localisation is in 
itself toxic. The disease mechanism in this explanation may arise through a 
resistance to ubiquitin mediated degradation. Problems associated with the 
machinery necessary to remove misfolded protein is a well-documented 
explanation of neurodegeneration, observed in X-linked ALS mutations in Ubiquilin-
2 [72]  and  dysfunction within the ‘Endosomal Sorting Complex required for 
transport’ (ESCRT) pathway [73].  Though it is still important to consider that 
elevated levels within the cytoplasm could also indicate toxicity through TDP-43 
nuclear evacuation,  which may mirror toxicity observed in TDP-43 knock-down 
studies in mice [34–36], drosophila [37,38,31] and zebra fish [39].  
Therefore, when relating disease associated mutations to disease onset, domain 
function should also be considered. Unfortunately, evidence to suggest that C-
terminal domain mutations disrupt the function of TDP-43 is limited, as many of 
this domain’s functional motifs are unknown or missing a large subset of mutations. 
Therefore, it is difficult to determine whether C-terminal mutations perturb a role 
of TDP-43 during disease. Thus, it is useful to pursue mutations that exist on a fully 
functionally characterised region with known structures and mutations to 
distinguish whether functional knock-down can explain common trends for disease 
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onset. Fortunately the RRM domains of TDP-43 are well annotated in regards to 
function and structure with each containing at least one disease mutation. 
Therefore, this study aimed to compare these domains against disease related 
mutations to examine whether loss of function or cytotoxicity could provide a 
common explanation and to substantiate further the auto-regulatory models 
proposed for disease onset.  
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Chapter II  
TDP-43 structure, homology and RRM-RRM domain 
insights 
 
2.1 TDP-43 structure 
 
TDP-43 homologs in humans and mice consist of 414 amino acids. The protein can 
be dissected into four functional domains to include the N-terminal (residues 1-
100), the RRM1 (residues 101-191), RRM2 (residues 200-262) and the C-terminal 
domains (residues 262-414) (Figure 1.2). The N- and C-terminal domains have no 
deposited structures, though they do display functional motifs involved in 
dimerization [65], nuclear import (residues 82-98) [74] and protein interactions 
[55,75]. The N-terminal is predicted to contain secondary structure by the PONDR 
prediction software (http://pondr.com) [62] and by computer assisted modelling 
[67]. The C-terminal structure is largely unknown, though a section (residues 311-
360) has been shown to form an ‘α-helix turn α-helix’ structure shown by NMR 
methodology including the residues involved in functional aggregation (residues 
318-343) [53]. There are no described structures for residues between 266-311 and 
361-414, containing 16/27 of the identified disease related positions. 
The TDP-43 nucleic acid binding region is well characterised and has three 
deposited models describing human RRM1 (PDB id: 2CQG), RRM2 (PDB id: 1WF0) 
by NMR and an X-ray crystallography model of mouse RRM2, bound to single 
stranded DNA, resolved at 1.65Å (PDB id: 3D2W) (Figure 2.1). The RRM1 adheres to 
the typical αββββα secondary structural RRM fold [76] whereas RRM2 contains an 
additional β-sheet arranged as αβββββα [77]. Both RRM domains contain two 
ribonuclear protein (RNP) variant motifs conserved in all RRM domains to 
orchestrate nucleic acid binding [76]. These are described as an eight (RNP1) or six 
residue (RNP2) consensus region  described as K/R-G-F/Y-G/A-F/Y-VI/L-X-F/Y [78,79] 
or I/V/L-F/Y-I/V/L-X-N-L [80] respectively where X is any amino acid.  
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The RRM1 secondary structures from the N’ to C’ terminals are arranged as 
β1α1β2β3α2β4. The RNP2 spans between residues 106-111 involving the β1 sheet 
whereas RNP1 is situated between residues 145-151 on the β3 sheet anti-parallel to 
RNP2 (Figure 2.1). Residues W113, F147, F149 and R151 have been specifically 
shown to bind nucleic acids in RRM1 [81] with W133 being situated on a flexible 
loop between β1 and α1 to show that the unstructured regions within the RRM are 
involved in ligand interactions. 
The RRM2 secondary structure is arranged as β1α1β2β3α2β4β5 and contains the 
nuclear export sequence (NES) (residues 239-250) spanning between the α2-helix, 
β4-sheet and connecting loop, conserved in both human and mouse structures 
(Figure 2.1). This is critical in the transportation of TDP-43 by exportin-5 across the 
nuclear membrane [82]. Interestingly this β4 sheet is oriented away from the 
remaining anti-parallel β-sheet platform and RNPs, suggesting that it is less likely to 
participate in nucleic acid ligand interactions. The RNP2 (residues 193-198) and 
RNP1 (residues 217-223) are situated on the β1 and β3 sheets respectively similar to 
RRM1. The high resolution ssDNA bound crystal structure of mouse identified 
residues K192, F194, R197, F221, R227, F231, S258, N259, A260 and E261 as 
capable of interacting with nucleic acid targets with high thymine-guanine content 
(TG) [77]. Given that the majority of nucleic acid contacts are orchestrated by 
several residues spanning the proteins anti-parallel β-barrel core. Domain unfolding 
is likely to change amino acid positions and possibly TDP-43’s nucleic acid binding 
affinity leading to changes in cellular function.   
The thermal stability of TDP-43’s RRM domains has previously been tested by CD, to 
indicate that RRM2 is structurally more stable [77]. The melting temperatures using 
the RRM domains of mouse demonstrated that RRM2 was stable up to at least 85˚C 
in contrast to 49.5 ± 0.7˚C for RRM1. Sequence homology between human RRM1 
and mouse RRM2 is 22.7% identical, however many similar propertied residues are 
conserved, especially surrounding the RNP regions described in further detail in the 
subsequent section (Figure 2.3). A couple of key structural differences exist 
between TDP-43 RRM domains that could explain this observation in stability. 
Firstly, the PDB structures of human RRM1 (PDB ID: 2CQG) and mouse RRM2 (PDB 
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id: 3D2W) can superimpose (RMSD of 0.9 Å) (Figure 2.2) to show that RRM1 has an 
extended loop region that does not form any additional contact with the main 
RRM1 body (Figure 2.2C). Without additional contact this extended loop is likely to 
be more flexible than its RRM2 counterpart which may lend to the unfolding of 
RRM1 during temperature denaturation. Secondly, the RRM2 contains more 
secondary structure namely from its additional β4 sheet (Figure 2.2E) which likely 
conveys stability through the β-sheet order and additional contact between 
neighbouring residues. The aliphatic index has been shown as a good indicator of 
thermal stability in globular bacterial proteins, where the amount of hydrophobic 
aliphatic side chained residues is positively correlated with protein thermal stability  
[83]. The alphatic index calculated from the domain sequences (Figure 2.2,A) are 
72.5 and 87.3 for human RRM1 and mouse RRM2, respectively (Expasy:Protparam), 
to suggest that aliphatic side-chains within these domains could mediate and 
substantiate the differences between domain stability.   
Although RRM1 is structurally more unstable than RRM2 it is important to note that 
it is stable under physiological temperatures and orchestrates the tighter affinity 
with DNA/RNA, explained in section 2.3, which may be aided by the additional 
positive residues contained in its extended loop region (Figure 2.2D).  
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Figure42.1 Deposited structures of TDP-43 RRM domains. The structural 
annotation of TDP-43 PDB deposited structures , where α-helices are shown in blue, 
β-sheets in red, loci of disease mutations as orange sticks, conserved RNP regions as 
green and NES in magenta.   A, The human RRM1 NMR structure of TDP-43. B, The 
human NMR structure of RRM2. C, The ssDNA bound RRM2 crystal structure of 
mouse RRM2. D, The ssDNA contacts made in the crystal model with the majority of 
contacts involving the anti-parallel β-barrel core. 
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Figure52.2 Structural comparison between human RRM1 and mouse RRM2.  A, 
Sequence homology between human RRM1 and mouse RRM2 performed by 
ClustalOmega [84]. The alphiphatic index was calculated as 72.54 and 87.35 for 
RRM1 and RRM2 respectively.  B, The PDB structures of these regions from PDB 
deposition 2CQG and 3D2W aligned with an RMSD of 0.9 Å. C,  Detailed view of 
unaligned residues in the extended loop region of RRM1. D, Possible polar contacts 
forming between the disease loci Asp169 (orange), Lys114 and Thr 115. E, The extra 
β-sheet of RRM2 not conserved in the RRM1 structure.    
 
 
2.2 RRM homology  
 
The RRM containing proteins are the most abundant in humans, expected to 
express in ~2% of all gene products [76]. RRM structures are conserved in 
eukaryotes, though sequences can vary, as illustrated using human proteins 
containing two tandem RRM domains with known structure (Figure 2.3). The 
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majority of conserved residues are situated within the RNP motifs that orchestrate 
nucleic acid binding in all RRM species, including TDP-43. Interestingly other than 
the RNP regions, the residues in the crystal structure of hnRNP A1 (PDB id: 1HA1) 
which form inter-RRM interactions are also predominately conserved in TDP-43’s 
tandem RRM region (residues 101-265) (Figure 2.3, red circles and Figure 2.4). 
 
 
Figure62.3 Homology between human proteins containing multiple RRM domains. 
The  sequence alignments performed by ClustalOmega [84] between human 
proteins containing multiple RRM domains. The majority of conservation is 
between the RNP regions responsible for orchestrating nucleic acid binding. 
Residues in dashed red circles were shown to form inter-RRM contacts in hnRNP A1 
crystal structure (1HA1) [85] the majority of which are conserved in TDP-43S. The 
proteins selected have following abbreviations:  TAR DNA Binding protein (TDP-43, 
PDB id: 2CQG, 1WF0), ELAV-like protein 4 (HUD, PDB id: 1FXL), heterogeneous ribo 
nuclear protein A1 (hnRNP A1, PDB id: 1HA1) and Poly(A)-binding protein (PABP, 
PDB id: 1CVJ).  Note that sequences do not vary significantly between RNP motifs as 
shown by the conservation bar in yellow. (Colours indicate ClustalX scheme, 
Appendix 1) 
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Figure72.4 Salt bridging between the RRM domains of HnRNP A1. A, The crystal 
structure of the tandem RRM regions of HnRNP A1 (UP1). B, The residues involved 
in the six salt-bridges stabilising the RRM domains of UP1, which is similar in 
sequence to residues 101-265 in TDP-43 (see Figure 2.3). 
 
RRM containing proteins usually comprise multiple RRM domains to increase 
specificity, affinity and selectivity that are important during function [76], as shown 
by ligand bound and unbound structures. For example, the tandem RRM domains 
of sex-lethal and nucleolin proteins tumble independently when not bound [86,87], 
whereas the RRMs of hnRNP A1 may interact to restrict movement and create a 
larger platform as shown in its crystal structure [85] (PDB id: 1HA1). When bound, 
the RRM-RRM regions of sex-lethal form a cleft in which RNA binds, whereas  ligand 
interaction in nucleolin also involves the linker [76]. The residue variations in-
between RNP regions therefore play an important function in how the RRM 
domains position for selectivity and binding. 
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The closest protein match to the TDP-43 RRM-RRM region is from hnRNP A1, 
known as UP1, which also contains two tandem RRM domains (PDB id: 1HA1). The 
identity between residues 101-265 of TDP-43 to UP1 is 36% and shares 54% 
similarity. Given that UP1 has a high resolution crystal structure, it is plausible that 
the RRM-RRM tandem domains of TDP-43 could also be resolved by X-ray 
crystallography.  
2.3 TDP-43S and its conservation between human and mouse 
 
Residues 101-265 containing the two tandem RRM domains is known as TDP-43S 
[77]. The TDP-43S structure and sequence are homologous between human, mouse 
and drosophila. The most similar to human is mouse, which is 93% identical and 
98% similar in sequence (Figure 2.5). In this comparison, RRM1 differs by one amino 
acid from Glu to Asp at position 122, therefore the structure of RRM1 is likely to be 
virtually identical between species. Changes between human and mouse RRM2 are 
minimal: the structure is conserved, as shown with the alignment between the 
NMR human and X-ray crystallographic RRM2 structures, which aligned with an 
RMSD of 0.66 Å (Chapter 5, Figure 5.5). The binding affinities are also comparable 
between species, binding (UG)6 with a Kd (nM) of 8.0 ± 0.7 and 14.2 ± 1.4, 
respectively for human and mouse, confirming that they are also functionally 
conserved [77,81].     
 
Figure82.5 TDP-43S sequence alignment between human and mouse. 
ClustalOmega [84] alignment of human and mouse TDP-43S sequences. Alignment 
shows the sequnces are 93% identical, or 98% considering similar amino acid 
substitutions (blue spheres). Only two dissimilar residues exist (yellow stars), which 
aren’t anticipated to change function as they do not occur within the RNP β-barrel 
core (green). Disease mutation loci are shown (red arrow) and secondary structure 
showing helices (blue) and sheets (red).  
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Study of the TDP-43S region for mouse has shown that the RRMs work in tandem to 
bind nucleic acid targets [77]. Importantly, the individual RRM domains have 
different ligand preferences, reflected by opposite trends of affinity to different 
lengths of single stranded uracil-guanine repeats (UG). RRM2 binds more strongly 
to (UG)3 with an affinity of 379 ± 123 compared to 4690 ± 629 Kd (nM) in RRM1. 
However, RRM2 binds longer (UG)6 with lower affinity at  4240 ± 381, which was 
tighter in RRM1, calculated as 65.2 ± 1.8 Kd (nM). This opposite trend in binding 
may reflect some specificity required by TDP-43 in selecting ligand targets for 
transport, splicing or sequestering nucleic acid targets.  
TDP-43S can bind (UG)6 tighter than both individual domains with a Kd of 14.2 ± 1.4 
(nM) suggesting that both RRM domains are required in orchestrating the binding. 
This synergistic behaviour suggests that the binding stoichiometry with the ligand is 
likely to be 1:1, which has been postulated using non-radiometric DNA binding 
assays with TDP-43 using single stranded (TG)6 [88].  
2.4 Mouse ‘TDP-43S’ as a model for disease related disruption 
 
Because mouse TDP-43S protein is homologous and includes a high resolution 
ssDNA bound crystal structure of RRM2 with data describing affinity  [77] it is well 
suited to model the human version of the protein. An advantage of using the mouse 
counterpart is that binding affinities and structural annotation regarding RRM1 and 
RRM2 can be incorporated to provide a comparative foundation during analysis 
[77]. The two mutant loci are conserved between species to describe sALS (D169G) 
[89] and FTLD-U (K263E) [90] to enable experimentation of how disease related 
mutants may contribute structurally and functionally to disease onset in the mouse 
species. The RRM homology between eukaryotes has established that the domain 
secondary structure arrangement is vital for function and therefore determining 
whether these mutations perturb TDP-43’s function or cause domain unfolding is 
an important step in understanding their significance during neurodegenerative 
diseases.    
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Therefore given the strong RRM structure to function relationship [76], TDP-43S is a 
suitable platform to establish whether mutations can cause changes to affinity. The 
C-terminus only has ~30% of its sequence annotated for function [55], to cover 
~40% of mutant loci not containing the most prevalent mutation A382T [54] 
(Chapter I, Figure 1.3). Therefore, at present the annotation of the C-terminal 
region is too complicated to clearly establish whether mutations affect TDP-43’s 
function. In contrast the RRM domains perform a single predominant role and 
therefore changes can be easily assessed by alterations to nucleic acid binding 
affinity and protein structure.  Every function described for TDP-43 is reliant on its 
interaction with nucleic acids and therefore is a logical construct to test whether 
onset arises through a loss of function as similarly described in the ‘gain of auto-
regulation’ model (Chapter I, Figure 1.1).  
The overall structure of TDP-43S will be assessed using small angle X-ray scattering 
(SAXS) in combination with existing high resolution atomic models for RRM1 and 
RRM2, to determine TDP-43S’ global shape. The differences in shape deduced from 
SAXS may then be compared to mutated proteins in order to explain whether 
disease mutations cause global structural changes e.g. RRM unfolding or inter 
domain interaction. Alongside this, the high resolution crystal structure of TDP-43S 
was sought to gain atomic details of the mutations, as similarly performed with UP1 
(PDB id: 1HA1).  
Protein structural stability tested by a resistance to thermal denaturation has been 
shown to correlate with increases to half-life in vivo [91–93]. This has been shown 
with mutations of inactive barnase (pseudo-wt barnase) isolated from E.coli. where 
an increase in thermal stability of 2.4 °C resulted in 14% more protein in the 
periplasm, providing a correlation between increased stability with reduced 
turnover [93]. Disease locations D169 and K263 exist on flexible regions within TDP-
43S and may move to orchestrate some additional stability by enhancing 
interactions. This will be assessed as previously performed with bacterial pseudo-
barnase protein [93] by comparing the mutant construct resistances to thermal 
denaturation. It is hoped that we can deduce whether RRM related disease 
mutations cause an increase to in vivo longevity as described for C-terminal 
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mutations. This would associate TARDBP disease related mutations occurring in two 
functionally separate domains (RRM and C-terminal regions) with a common 
mechanism of disease onset, independent from nucleic acid binding function. 
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Chapter III 
Cloning, expression and the purification of mouse 
TDP-43S 
 
3.1 TDP-43S cloning rationale 
 
A prerequisite for the examination of the TDP-43S construct utilising the bio-
physical techniques available was the development of an expression system 
capable of producing a high yield of >95% pure protein in vitro. The homogeneity is 
specifically important for small angle X-ray solution scattering (SAXS), circular 
dichroism (CD), differential scanning fluorimetry (DSF) and aromatic residue 
fluorescent tracking, since contaminants cannot be differentiated during data 
analysis.  
To this end, E.coli was used to over-express tagged mouse TDP-43S protein from 
recombinant plasmid DNA. The benefits of this system meant a high yield of protein 
could be produced in large volumes using Luria-Bertani broth in a relatively short 
time frame. E.coli has been shown to express sufficient quantities of N-terminally 
histidine tagged mouse TDP-43S [77] using the M15 strain. However, this study 
opted for the basic DE3 strain (Appendix 2) which lacks the lac repressor plasmid 
‘pREP4’, responsible for avoiding protein leaking in the absence of galactose or 
Isopropyl β-D-1-thiogalactopyranoside (IPTG). This change did not significantly 
affect the expression levels of TDP-43S protein providing a yield of ~8 mg/L of 
culture. 
 
3.2 GST solubility tag 
 
A Glutathione-S-Transferase (GST) tag was incorporated onto the N-terminal of 
TDP-43S. GST has a MW of 25 kDa and readily forms a stable 50 kDa homo-dimer. It 
is highly soluble and is commonly utilised to increase the likelihood of increasing 
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the solubility of the fusion protein [94,95]. This was exploited to obtain good yields 
of soluble GST-TDP-43S during early expression,  similar to other GST tagged TDP-43 
constructs [23,49]. In addition to this, GST can be purified by affinity 
chromatography to maximise the yields of TDP-43S and reduce the amount of 
purification steps. Exploiting the GST interaction to glutathione, commercial 
columns are readily available (GE healthcare) to facilitate the fusion proteins 
efficient purification by affinity chromatography. The incorporation of a GST tag 
was also used to maximise the likelihood of obtaining GST-TDP-43S crystals through 
increasing the number of crystal contacts [96,97]. As shown in the crystallisation of 
GST-fused ‘DNA replication-related element binding factor’ (DREF) a DNA binding 
protein that failed to crystallise prior to this tagging [98].    
The pGEX3X expression vector encodes a tetrapeptide factor Xa protease cleavage 
site with the sequence; Ile-Glu-Gly-Arg situated between GST and TDP-43S to 
facilitate tag removal. Due to the plasmid vector’s design, three non-native amino 
acids, Gly, Ile and Leu, are retained on the TDP-43S N-terminal end after cleavage. 
However, they did not appear to affect the construct’s DNA binding affinity when 
compared against previously published Kd values for TDP-43S [77] or its oligomeric 
state (discussed in Chapter VII).  
 
3.3 TDP-43S protein expression 
 
The pGEX3X TDP-43S plasmid, (mTDP-43SpGEX3X, Appendix 3) contained a tac 
promoter  [99] activated to signal protein over-expression in the presence of IPTG. 
The amount of IPTG, temperature and incubation time needed was determined by 
expression trials set within the recommendations described in the manufacturers 
protocol (GE Healthcare) (data not shown).  
GST-TDP-43S over-expression from E.coli was most efficient using 5 mM 
IPTG and a 5 hour incubation at 30˚C. By minimising the amount of purification 
steps, this procedure produced high yields of >95% pure GST-TDP-43S protein. The 
purity could still be maintained even when cleaving the GST-TDP-43S protein whilst 
bound on the glutathione column, although some yield was compromised by the 
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efficiency of factor Xa cleavage, meaning some fusion protein remained bound. The 
purity could be improved to ~99% by passing down a gel filtration chromatography 
column (Superdex 200 16/60) (Figure 3.1). The yield of TDP-43S was estimated as 8 
mg per litre of culture. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure93.1 Purification of GST-TDP-43S and TDP-43S. The purification of cleaved 
TDP-43S was achieved in three purification steps. The soluble fraction shows over-
expression at ~40 kDa representing GST-TDP-43S.  After GSTrap elution, purity of 
TDP-43S is ~95%. The remaining contaminants can be removed by gel filtration to 
produce 99% pure TDP-43S protein.  
 
3.4 TDP-43S identification by mass spectrometry 
 
The GST-TDP-43S mass was calculated at 45 kDa by sequence analysis (EXPASY: 
protparam), but ran as a 40 kDa protein on a 12% acrylamide SDS-PAGE (Figure 3.1). 
To rule out truncation the purified samples were analysed by electrospray 
ionisation mass spectrometry (ESI-MS) to empirically determine its mass. Using this 
technique, the correct GST-TDP-43S protein size was verified as 45 kDa (Figure 3.2) 
but factor Xa cleaved TDP-43S could not be detected, presumably caused through 
problems regarding either protein protonation or aggregation.  
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TDP-43S has a theoretical weight of 19.1 kDa but also ran slower on a gel at ~15 
kDa. Therefore to identify and account for more of its mass its gel band was cut and 
amended to a trypsin digest and matrix assisted laser desorption/ionisation time of 
flight (MALDI-TOF) mass spectrometry (MS) (Figure 3.2). The resulting MS fragment 
fingerprint could account for 17 kDa and correctly matched several theoretical TDP-
43S fragment masses to correctly identify the protein (EXPASY:PeptideMass).  
Since GST-TDP-43S was expressed, bacterial cleavage was not thought to occur. The 
tendency of GST-TDP-43S to behave as a smaller protein on an SDS-PAGE was also 
assumed for GST cleaved TDP-43S so it is likely to be the full sized protein. 
 
  
Figure103.2 MS-MS analysis of full length GST-TDP-43S and trypsin digest of TDP-
43S. The mass spectrometry results of expressed TDP-43S constructs. A, Full length 
GST-TDP-43S 45 kDa mass (EXPASY:protparam) was confirmed by ESI-MS/MS. B, 
The expected trypsin fragments of TDP-43S from the sequence (EXPASY: 
PeptideMass). C, The MALDI-TOF MS of trypsin digested TDP-43S fragments. These 
account for 17 kDa of TDP-43S, which verifies that the correct protein was being 
expressed. 
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3.5 Retention and removal of RNA/DNA bound to TDP-43S  
 
During the expression of TDP-43S, the protein bound bacterial nucleic acid which 
were retained throughout purification. This was revealed through monitoring the 
ratio between the 260 and 280nm wavelengths. This ratio is commonly used for 
tracing contaminant nucleic acids in a protein sample [100]. A 260:280 nm ratio 
between  0.6-0.8 has been previously shown to be sufficient in removing nucleic 
acid contaminants in a control protein; Enolase and in established biochemical 
methodology [100,101]. The addition of 500 mM NaCl was sufficient in removing 
bound DNA/RNA (Table 3.1) and was included as an additional wash step whilst the 
protein was bound to the GSTrap column. 
 
 
Table13.1 Removing TDP-43S bound nucleic acids by increasing salt concentration 
 NaCl (5mM) NaCl (500mM) 
Repeats 260nm 280nm 260/280 260 280 260/280 
1 0.360 0.360 1.00 0.214 0.296 0.72 
2 0.087 0.075 1.16 0.079 0.103 0.76 
3 0.225 0.274 0.84 0.189 0.276 0.68 
 
3.6 The oligomeric state of TDP-43S determined by gel filtration chromatography 
 
The TDP-43S protein has been shown to elute as either a dimer [77] or monomer 
[102]. During this study, mouse TDP-43S was found to be monomeric as compared 
against a calibrated gel filtration profile using myoglobin (17 kDa), superoxide 
dismutase-1 (SOD1) dimer (32 kDa) and bovine serum albumin (BSA) (67 kDa) even 
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in the absence of reducing agents. TDP-43S eluted between the SOD1 dimer (32 
kDa) and myoglobin (17 kDa) which coincides well with the expected 19.1 kDa mass 
of TDP-43S (Figure 3.3). This supports previous findings that show that the N-
terminal is important in orchestrating the contacts necessary for dimerization 
[60,102].  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure113.3. Gel filtration chromatography purification and oligomeric state of 
TDP-43S. TDP-43S Superdex 200 16/60 elution profile calibrated against protein 
standards; myoglobin (17 kDa), superoxide dismutase-1 (SOD1 dimer) (32 kDa) and 
bovine serum albumin (67 kDa). The TDP-43S protein eluted predominately as one 
peak between Myoglobin and SOD1, which fits well with a 19 kDa TDP-43S 
monomer prediction 
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3.7 Expression and the gel-filtration of mutant TDP-43S 
 
Disease associated mutations were generated from the same mTDP-43SpGEX3X 
plasmid template by mutagenesis. As such, the same protocol was repeated for 
both D169G and K263E disease mutants. Mutant plasmids (Appendix 3) expressed 
and purified no different as described for wtTDP-43S and the gel filtration profiles 
were identical (Figure 3.4).  
 
 
 
Figure123.4 Mutant and wild-type gel filtration profiles.  Wild-type and mutant 
constructs eluted at the same volume down a Superose 12 300/10 column, 
indicating that their mass and oligomeric state are similar, the mutants do not 
enhance TDP-43S oligomerisation. 
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3.8 TDP-43S crystallisation trials 
 
To generate crystals for X-ray crystallography wild-type and mutant TDP-43S  were 
screened using commercial crystallisation conditions. The constructs were setup 
using vapour diffusion trays either using hanging or sitting drop methodology 
depending on access to the high throughput robot (Figure 3.5). Protein samples and 
the reservoir solution used to constitute the sample drops were mixed in either a 
1:1 or to increase protein concentration  a 2:1 protein reservoir ratio. In each case 
the protein concentration was within a final 5-10 mg/ml concentration, suitable for 
super saturation of a small protein (~19kDa) [103]. The crystallisation of TDP-43S 
was anticipated based on the crystal structure of the tandem RRM-RRM domains of 
hnRNP A1 [85] and the TDP-43s’ RRM2 [77]. 
A significant effort was put into the crystallisation of TDP-43S as a high resolution 
structure of the mutations and RRM-RRM arangement could determine whether 
mutations disrupt the structure. Despite testing over a 1000 different conditions, 
using both GST-tagged and untagged TDP-43 variants no protein crystals were 
observed. This effort is summarised in the table below (Table 3.2) 
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Figure13 .5 Crystallisation trial setups. Protein supersaturation is a prerequisite for 
crystallisation and is typically achieved by removing water and increasing 
precipitating agent (ppt) concentration. This is commonly achieved by via vapour 
diffusion methodology. The drop can be placed on A, the roof of the well, used in 
trials setup manually or B, on a shelf typical for automated trials setup by robot. C, 
Both setups remove water by diffusion from the higher water content of the drop, 
containing the protein of interest, to the lower content of the reservoir in a closed 
environment until ppt concentration is equal.
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Table23.2 TDP-43S crystallisation conditions 
Crystal screen Nº of 
conditions
 
Crystals  Diffraction Temp 
(°C) 
TDP-43S 
variants 
WT GST-
TDP-43S 
Concentration 
(mg/ml) 
Vapour diffusion 
Morpheus (Molecular Dimensions) 96 3 Salt 4/RT WT, KE, DG N 5-10 Sitting/Hanging 
Natrix (Hampton Research) 96 4 Salt 4/RT WT, KE, DG N 5-10 Sitting/Hanging 
JCSG Plus (Molecular Dimensions) 96 7 Salt 4/RT WT, KE, DG Y 5-10 Sitting/Hanging 
PACT premier (Qiagen) 96 6 Salt 4/RT WT, KE, DG Y 5-10 Sitting/Hanging 
PEG/ION HT (Hampton Research) 96 3 Salt 4/RT WT, KE, DG N 5-10 Sitting/Hanging 
HnRNP A1 (Custom) 48 0 N/A 4 WT N 5-10 Sitting/Hanging 
RRM2 mouse TDP-43 (Custom) 48 0 N/A 4 WT N 5-10 Sitting/Hanging 
Index HT (Hampton Research) 96 0 N/A 4 WT N 5-10 Sitting/Hanging 
Salt Rx 1 & 2 (Hampton Research) 96 0 N/A 4 WT N 5-10 Sitting/Hanging 
Wizard 1 & 2 (Emerald Biosystems) 96 0 N/A 4 WT N 5-10 Sitting/Hanging 
Classic Suite (Qiagen) 96 0 N/A 4 WT N 5-10 Sitting 
MPD Suite (Qiagen) 96 0 N/A 4/RT WT Y 5-10 Sitting 
AmSO4 Suite (Qiagen) 96 0 N/A 4/RT WT N 5-10 Sitting 
pH Clear 2 Suite (Qiagen) 96 0 N/A 4/RT WT N 5-10 Sitting 
PEGs Suite (Qiagen) 96 0 N/A 4/RT WT N 5-10 Sitting 
MbClass Suite (Qiagen) 96 0 N/A 4/RT WT N 5-10 Sitting 
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Chapter IV 
Techniques used to characterise the structure of TDP-
43S 
4.1 Small angle X-ray solution scattering (SAXS) 
 
Small angle X-ray scattering (SAXS) is a technique often used to deduce the overall 
shape and size of a macromolecule in solution. The RRM domains of TDP-43 have 
well defined structures that may interact with each other in order to orchestrate 
the protein’s interaction with nucleic acids, as observed in the hnRNPA1 crystal 
structure [85]. To determine whether this interaction is observed in solution for 
TDP-43S and whether mutations influence inter RRM interactions the solution 
based SAXS techniques were used. The SAXS analysis suite ATSAS [104] contains 
several programs developed to generate the average 3D shape, linker flexibility and 
RRM-RRM interactions of TDP-43S in solution. Through establishing a 3D structural 
model of wild-type TDP-43S, models of disease mutants can be built and compared 
to determine global structural differences.   
SAXS is a low resolution technique typically capable of a resolution of up to 10-20 Å, 
limited by the rotational averaging of the protein’s shape and structural parameters 
in solution [105]. It is one of two versatile techniques developed since the discovery 
of X-rays, the other being X-ray crystallography. Both techniques exploit the plane 
wave properties of X-rays which can be described by its amplitude and wavelength 
and its interaction with electrons. It is from these scattered secondary wavelets 
that constructively or destructively interfere with each other and their angles that 
are exploited during data interpretation.  
The scattering from macromolecules at low angles in solution generates an 
isotropic profile on the detector with a characteristic intensity decreasing from low 
to high angles. From the 1D scattering profile one cannot discriminate between 
scatterers of different size and shape, therefore it is important that the sample is 
monodispersed and free from oligomeric or aggregated states. The smallest angle 
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which can be measured in SAXS defines the longest distance of the macromolecule, 
thus the region close to the beam-stop is most sensitive to aggregates and 
unwanted scatterers.  
To this end the SAXS beam-line at the Soleil synchrotron, St Aubin, France, named 
SWING, has a coupled high performance liquid chromatography (HPLC) column to 
increase the likelihood that the desired proteins are monodisperse immediately 
prior to X-ray exposure [106]. The protein’s elution through the column can be 
calibrated so that SAXS data can be recorded once the elution volume containing 
the protein of interest is known (Figure. 4.1). 
 
Figure144.1 Schematic of HPLC coupled SAXS data collection. Data collection setup 
at Soleil, St Aubin, France on the SWING SAXS beam-line. A small sample volume 
~40ul is automatically injected whilst in the experimental hutch. The sample is 
passed down a HPLC size exclusion column which ensures the sample is 
homogenous (red in the elution profile) in the absence of aggregates depicted in 
the void volume (left of the dashed line). The X-ray is calibrated to measure the 
elution of the sample as it runs through the X-ray permeable cell, since the sample 
is consistently moving X-ray damage is also minimised compared to a stationary 
sample. The centre of the isotropic profile has no scattering due to the beam stop, 
present to avoid permanent damage to the detector. Some information within this 
region can be calculated by extrapolating the data from the remaining low angle 
signal. 
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4.2 SAXS theory 
 
The scattering pattern of a macromolecule in solution can be described by the 
intensity (I) as a function of the scattering angle  . Generally the scattering angle 
alone is not disclosed, instead it is usually quoted as the length of the scattering 
vector  ⃗ related to  , known as momentum transfer (q) measured in Å-1 (Equation 
4.1); 
q = 
      
 
 
 
(Equation 4.1) 
Where λ denotes the wavelength and θ is half the angle between the incident and 
scattered radiation. Non-crystalline particles scatter as described by Debye et. al 
1915  [107]. The contribution of each scattered particle to the detectable signal can 
be explained by the following relationship [108]; 
I(q)= ⟨∫  |( ( ⃗⃗)   ̅ ) 
  ⃗⃗  ⃗⃗  ⃗⃗|  ⟩ 
 
(Equation 4.2) 
Where the brackets 〈 〉 denote the rotational averaging of the sample and  ( ⃗)   ̅
 
 
is the difference in the scattering densities between the measured scattering 
particle at the volume element position ( ⃗) and that of the solvent (s)[108]. 
Essentially the signal used during analysis is the scattering of the protein of interest 
with the scattering of the solvent subtracted.  The integration of scattering data 
over all directions yields the one-dimensional isotropic I(q) Vs q plot, from which 
all valuable geometric information of the protein can be calculated such as the 
radius of gyration. 
 
4.3 Radius of gyration (Rg) 
 
The radius of gyration (Rg) is the first piece of information regarding the shape of 
the macromolecule defined as the root-mean-squared distance of scattering 
particles weighted about its centre of mass, usually quoted in Å. Since 
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macromolecules of the same mass but different shapes yield different values it can 
be exploited to detect initial differences between mass distributions.  
The Rg can be determined by two methods. Either by Guinier approximation 
(Equation 4. 3) [105] or by the interatomic distance distribution profile (P(r)) 
obtained by a modified Fourier transform of the I(q) Vs q plot (Equation 4.4).   
In the Guinier approximation the Rg is calculated from the linear region at the 
smallest experimentally available angles in a Guiner plot (In[I(q)] Vs q2) (Equation 
4.3). This profile is only linear over a limited region, typically for globular proteins a 
qRg <1.3 but is dependent on the structural characteristics of the macromolecule 
under study.  For intrinsically disordered proteins this range can be reduced to qRg 
<0.8 reflecting the complexity arising from flexibility and different conformations in 
solution [109,110].  
Calculating the Rg from the P(r) profile utilises the entire scattering curve (Equation 
4.5) and is not influenced by the restrictions associated with Guinier approximation. 
However, the errors associated with assigning an accurate maximum intra-atomic 
distance known as Dmax can be influenced by flexibility within a species. For 
purposes of accuracy, both methods are used for comparison.   
Guinier approximation as determined by the straight line equation at small angle in 
a In[I(q)] Vs q2 plot; 
    ( )      ( )   
   
 
     
        y    =    c         -       m        x 
(Equation 4.3) 
I(0) is the extrapolated intensity at q=0. The straight line components, depicted in 
red are used to generate the Rg from the gradient; 
 
    √   
 
(Equation 4.4) 
Where m is the line gradient. 
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Equations for the Rg as determined automatically from e.g. Gnom [111] using the 
P(r) profile [110], equation (4.5); 
    √
∫  ( )    
    
 
 ∫  ( )  
    
 
 
 
(Equation 4.5) 
Where P(r) is related to the frequency of distances at a particular inter-atomic 
distance (r). 
 
4.4 Interatomic distance / P(r) profile 
 
The P(r) profile is the summation of all distances between scattering centres within 
the protein, depicted by their frequency at each vector length (r) to Dmax (Figure 
4.2). This essentially describes the mass distribution of the macromolecule and can 
be utilised as an input for ab initio modelling.  
The P(r) profile can indicate flexibility or intrinsically disordered proteins which is 
suggestive of an elongated tail before an appropriate Dmax can be assigned. This 
reflects the different sized populations used to generate the scattering data. 
Examples of this can be observed in the work of Receveur-Brechot and Durand, 
2012  [110].  
 
4.5 Kratky plots 
 
Plotted as I(q)q2 Vs q, the Kratky plot can be used to differentiate between folded 
globular proteins and those that are completely disordered. This plot is a measure 
of surface interfaces as described by Porods law [112] .  
In a globular species, not all residues are accessible to solvent which tend to be 
masked in the core of the protein. Therefore, the ratio between protein mass and 
solvent surface accessibility is reduced. This results in a bell curve returning to zero 
as q increases in the plot [110]. Conversely in a completely unfolded species no bell 
curve is observed and tends to increase in I(q)q2 as q increases. A flexible protein 
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containing structure could straddle both profiles, depending on the extent of the 
protein’s flexibility [110]. This plot is able to show folding differences between 
mutant profiles but lacks the detail necessary to deduce how this change is derived. 
An adaptation to this plot, a dimensionless Kratky, removes the size and shape 
contribution to allow for direct protein comparisons [113]. This plot is performed as 
above but the y and x axis are divided by the I(0) (the I(q) when 2 =0) and 
multiplied by the protein’s Rg respectively to remove molecular mass and size 
contributions [110]. This adaptation fulfils two roles. Firstly, it allows the direct 
comparison of proteins through scaling and secondly, proteins can be compared 
against known annotation whose trend for a well folded globular protein peaks at 
1.104 I(q)q2/I(0) at √3 the qRg. Deviations from this represent varying degrees of 
flexibility, disorder and unfolding as commonly seen in intrinsically disordered 
proteins [110].     
 
Figure154.2 Primary SAXS profiles. Examples of A, the 1 dimensional SAXS profile (1D 
profile). B, Interatomic distance (P(r)) profile and C, the kratky plot, depicting the 
integral expected in a globular protein (dark grey). 
 
4.6 Ab Initio modelling 
 
From a 1D profile it is possible to model the 3D shape of the protein through ab 
initio modelling.  Several ab initio programs are incorporated within the ATSAS SAXS 
interpretation software suite, of these, GASBOR [114] was employed within this 
study.   
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In this method the model of the macromolecule is constructed from dummy 
residues resembling Cα of each amino acid within the protein. The algorithms 
employed by GASBOR aim to compact these residues from a dispersed gas-like 
volume to agree with the dimensions and mass distributions of the SAXS profiles. 
The constraints require the model to adhere to the ‘chain-compatibility’ spatial 
arrangement meaning Cα are situated 0.38 nm from each neighbour representing 
the spatial separation of a peptide bond [114]. The dummy residues are scaled by 
the average amino acid mass in order to represent the correct I(q). Monte Carlo-like 
algorithms are employed to search for better fits to the 1D scattering data and the 
goodness of fit is assessed by   minimisation [111].  It is usually appropriate to 
generate a number of GASBOR repeats for 3D superimposition, then averaging the 
models to establish the average model. Average models are also fitted to the 1D 
data to assess whether the model is in agreement with experimental scattering.  
4.7 Rigid-body modelling 
 
The high resolution PDB structures describing TDP-43 RRM domains can also be 
considered when fitting to the 1D SAXS curve. By incorporating known structural 
features during ab initio modelling we derive further evidence for the shape and a 
more realistic domain arrangement in solution.  
A protein can be explained by any number of atomic structures assuming they 
describe a unique section of the macromolecule. The relationship for rigid-body 
structures (k) and its scattering contribution can be explained with the equation 
below (Equation 4.6)[115].   
 ( )   ⟨ | ∑  ( )( )
 
   
|  ⟩    
 
(Equation 4.6) 
Where A(k)(q) is the scattering amplitude of the kth rigid-body and 〈 〉    is the 
rotational spherical averaging in reciprocal space. For regions that lack structural 
annotation such as the linker and terminal regions in TDP-43S an ab initio approach 
can be combined during analysis. This is performed by the ATSAS program BUNCH 
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to describe the entire I(q) signal including the rigid-bodies and dummy residue 
traces which considers rotations, distances and orientations of sub-structures [115], 
described as (Equation 4.7); 
 ( )     ∑ ∑ |∑   
( )
 
 
 
    
 
   
( )   ∑   
( )
 
( )|   
 
 
(Equation 4.7) 
Where    
( )
(q) and     
( )
 (q) denote the partial scattering amplitudes of the kth rigid 
body and dummy residues respectively.  
The closeness of fit to the experimental data is calculated again by minimising    
values  to indicate improved fits when dummy residues and rigid-bodies are 
orientated into a more favourable conformation [115]. The software does not allow 
spatial overlap between structures or infeasible rotation angles. Side-chains 
attached to Cα-atoms can be reconstituted using the online software SABBAC [116]. 
It is usually appropriate to test the fit of ab initio models by fitting the final 
reconstituted structures back to the original data by CRYSOL [117] to determine if 
the model correctly represents the data.  
4.8    minimisation 
 
Caution is required when assessing   values since this value is also influenced by 
the scale and quality of the SAXS data. For example    fits match noisy data easier 
since the error is increased so values are more likely to stray within its bounds. 
Obviously large   values indicate poor fits but one should also assess the actual 
plot to see if it can accurately match the data up to a sensible q(Å-1) value. They can 
therefore be used to choose the best fit between similar profiles of the same 
species.    minimisation is calculated as shown in Equation 4.8 (using BUNCH) 
[115]. 
    
 
   
 ∑[
    (  )    (  )
 (  )
]
 
 
 
(Equation 4.8) 
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Where   is the number of experimental points, c is the scaling factor and   (  ) the 
experimental error at momentum transfer (qj). 
4.9 Ensemble optimisation methodology (EOM) 
 
In a flexible species the experimental SAXS curves can be considered to be made 
from the sum of populations characterised by different conformations. The 
ensemble optimisation method (EOM) [118] attempts to determine the frequency 
of these populations using a pool of random theoretical models limited by the 
sequence length and any user defined PDB depositions describing parts of the 
protein. This approach can be used to estimate the extent of protein flexibility in 
solution [118] as shown in other RRM-RRM species [119]. 
EOM generates 10,000 random models testing the entire spatial configuration 
space of the protein. The theoretical scattering of these models are compared and 
changed in proportion according to the best fit to the 1D experimental curve by  2 
minimisation. The output of EOM yields the ratio of protein sizes displayed as a 
histogram in regards to both Dmax and Rg needed to fit the observed curve. The 
models used during this fit are available so conformation or spatial distances can be 
compared.   
4.10 Circular dichroism (CD) 
 
Circular dichroism (CD) is a biophysical technique which exploits absorbance 
differences between left and right circular polarised light (CPL) typically between 
the 178 – 260 nm wavelength ranges. Throughout this spectrum  CPL is absorbed 
differently depending on the composition and type of protein secondary structure 
and can be used to predict the relative proportion within a protein of interest [120]. 
Its use during this project was to characterise any initial structural differences 
between native and disease related mutations of TDP-43S which could be used to 
support the global observations extracted by SAXS.  
Differences of protein absorption between left and right circular polarised light 
(CPL) plotted as a function of wavelength is proportional to the content of 
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secondary structure, as described in Figure 4.3. This data is typically analysed 
through structural algorithms that compare the spectrum against an annotated 
reference set of proteins and assigns based on this the relative secondary structure 
content.  
As part of the dichroweb on-line CD analysis suite [121] there are several algorithms  
that can analyse  CD spectra. However, for reasons of relevance only the CDSSTR 
algorithm will be discussed, since it was used during this study. 
CDSSTR uses singular value decomposition techniques to compare  5 features over 
the 178-260 nm range between sample and reference spectra [122]. This avoids 
over interpretation and reduces any anomalous errors introduced through 
contaminant absorbers, noise or the instrumentation introduced during analysis 
[122,123]. This technique has been  described as one of the most thorough analytic 
packages for CD analysis and has been found to perform best when using longer 
wavelength ranges with  smaller reference sets, as compared to other commonly 
used algorithm [124] such as CONTIN [125] and SELCON3 [126]. 
 
Figure164.3. Contribution of secondary structure on a CD spectrum. The circular 
dichroism absorbances of secondary structure. Showing the difference between 
absorbance of left and right circularised light, shown in millidegrees. The schematic 
is adapted from   Brahms & Brahms, 1980 [127]. 
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Chapter V 
Assessing the effect TDP-43 RRM disease mutations 
have on global structure by small angle X-ray 
scattering and circular dichroism 
 
5.1 Exploring the properties of RRM-RRM domains in solution 
 
The TDP-43S construct is known to contain two structured RRM domains separated 
by a linker of unknown structure. Through comparisons made from other tandem 
RRM proteins, discussed in chapter II, similar linkers are often flexible, enabling 
individual RRMs to move independently. This could also be true of TDP-43S given 
that it also failed to crystallise, which is likely due to flexibility (Chapter IV, Table 
3.2). Therefore, to draw meaningful conclusions about a protein’s dynamic 
structural behaviour, describing e.g. protein unfolding, flexibility and inter-domain 
interactions, one should draw conclusions from solution based methodology. These 
findings also relate better to TDP-43’s natural behaviour in vivo, compared to a 
protein crystal for example, which may restrict movement by crystal packing.   
The technique used during this study was small angle X-ray solution scattering 
(SAXS), discussed in further detail in chapter IV. The main limitation of SAXS is its 
low resolution, caused by averaging different protein orientations within the 
sample. However, this is also beneficial, since the data collected provide 
information regarding the protein’s average shape. Therefore, structural changes 
that infer a change to the maximum length or remove electron density should be 
reflected in the deduced SAXS models. This could occur through TDP-43S mutations 
by increased inter-domain interaction or domain unfolding, which would be 
anticipated to cause a more condensed or expanded structure respectively. 
SAXS models are  also complementary to high resolution techniques  used to 
superimpose high resolution structures to assess their conservation in solution 
[128,129]. NMR and crystallographic structures can also be useful during the 
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generation of SAXS models to account for domain electron density. The two 
functional RRM domain structures previously solved by NMR and X-ray 
crystallography (PDB deposits; 2CQG & 3D2W respectively) for TDP-43 and can 
therefore be incorporated by SAXS methodology to provide constraints when 
determining the spatial arrangements and flexibility of the tandem RRMs in 
solution.  
5.2 Suitability of SAXS to assess differences between TDP-43S mutants  
 
The growing sophistication of analytical programs available to analyse scattering 
data means that SAXS can now provide information regarding the average ab initio 
shape, the radius of gyration, the particle’s maximum dimension and an estimate of 
the different conformations within the sample. SAXS has been widely used to 
investigate structural changes in both globular and flexible protein species 
[119,130]. 
SAXS is sensitive enough to differentiate between the spatial differences of two 
RRM-RRM proteins during ligand binding, despite sharing a similar domain 
organisation [119]. The ensemble optimisation SAXS methodology combined with 
surface plasmon resonance (SPR) could determine differences of RRM positioning 
during ligand binding between TIAR and HuR, two proteins which contain two 
tandem RRM domains. This demonstrates that data derived through SAXS can be 
used to successfully analyse similarly organised proteins to TDP-43S.    
SAXS with use of partially known structure has also been used to describe the 
structure of a full length RRM containing protein, as shown for polypyramidine tract 
binding protein (PTB).  Using a combination of scattering curves for different RRM 
pairings and individual rigid-bodies the results produced just one valid 
conformation to describe the arrangement of the four RRM domains of the PTB 
structure which has eluded crystallography and NMR approaches [130].  
SAXS is therefore an appropriate technique to explore differences between the 
global structure of TDP-43S and disease mutants. As such  RRM-RRM spatial 
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arrangements, structural unfolding and flexibility of different mutants were 
assessed and compared.  
5.3 TDP-43S SAXS data collection 
 
SAXS data were collected at the Soleil synchrotron, taking advantage of the on-line 
HPLC coupling and purification immediately prior to data collection. This ensured 
that protein samples used for subsequent analysis were homogeneous and 
aggregate free, as highlighted in Chapter IV. Datasets were collected using 1 second 
exposures, with 0.5 second dead-time over 255 frames. These frames were 
calibrated to collect the proteins elution from size exclusion chromatography. The 
high intensity associated with synchrotron X-ray radiation and collection time per 
frame meant the radius of gyration (Rg) could be estimated to monitor the Rg and 
I(0) during the dataset.  The sample in solution was in constant motion during the 
dataset to limit the amount of radiation damage. 
The components used to make up the Rg Vs I(0) plot (Figure 5.1) are related to 
protein size and concentration respectively so that data from the highest protein 
concentration could be pooled. Limiting the data to the more intense scattering of 
higher protein concentrations meant that noise was reduced and improved signal 
could be measured at higher q(Å-1) ranges. Frames between 220 – 231 
corresponding to a steady Rg (~22Å) at the highest I(0) were averaged and used to 
generate the 1 dimensional plot (1D) (Figure. 5.2). 
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Figure175.1. The Rg vs I(0) plot of wtTDP-43S HPLC elution. The elution of TDP-43S 
through the size exclusion column were analysed by SAXS to yield the scattering 
intensity I(0) and radius of gyration (Rg) used to identify frames 220-231 for 
pooling.  
 
5.4 Approximation of Dmax and the radius of gyration  
 
The pooled data resulted in a low error in the 1D profile up to a q(Å-1) of 0.5 (Figure 
5.2) with an Rg estimate of 21.8 ± 0.1 Å (data points 1-101), determined by the 
Guinier approximation  (Figure. 5.3). The data within the qRg <1.3 limit compared 
reasonably well with other RRM-RRM structures, with an Rg of 20 Å calculated for 
UP1 (PDB id: 1UP1 by CRYSOL [117](data not shown).  
The 1D profile was re-plotted to produce the pair-wise distribution function (P(r)) to 
assess the distribution of mass (Figure 5.4). The maximum interatomic distance 
(Dmax) in the P(r) was calculated as 85.5 Å the distance frequencies clustered at  
~20 r(Å) and at ~40 r(Å) to a lesser extent with a couple of smaller shoulders at 
higher distances. These two larger distance frequencies likely reflect the masses of 
the two RRM domains. The profile immediately prior to the Dmax is elongated 
similar to other flexible multi-domained proteins to suggest that TDP-43 was also 
flexible [110,131]. The Rg calculated from this Guinier approximation plot was 
larger at 23.3 ± 0.1 Å probably attributed to having to assign a large Dmax to allow 
for a reasonable fit of data, shown in Appendix 4. The regularised fit to the data is 
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based on the ‘perceptual criterion’ method established by Svergun (1992), 
implemented and performed automatically in the GNOM program [111], to 
establish a regularised fit to the experimental data. 
 
 
 
Figure185.2  1 dimensional profile of wtTDP-43S.  The pooled frames 220-231 gave 
rise to the 1D profile for wtTDP-43S.   
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Figure 195.3 Guinier region and approximation of wtTDP-43S. The Guinier 
approximation of wtTDP-43S estimated the Rg as 21.8 ± 0.1 Å with qRg limits < 1.3. 
   
 
 
 
 
 
 
 
 
 
 
 
Figure205.4 Pair-wise distribution profile wtTDP-43S. The P(r) profile of wtTDP-43S 
estimated a maximum interatomic distance of 85.5 ± 5Å and Rg of 23.3 ± 0.1 Å.  The 
p(r) axis represents the relative frequency of inter-atomic distances and r(Å) the 
distance.  
60 
 
5.5 Kratky plot and molecular weight estimations. 
 
The 1D curve conversion to the I(q)q2 Vs q (Å-1) Kratky plot produced a profile 
containing characteristics observed for disorder and folded protein [110]. An 
incomplete bell curve suggestive of globular structure is present between the 0.00 - 
0.25 q(Å-1) range however was incomplete and increased in signal at higher q(Å-1) 
angles. This is a trend observed from flexible proteins [132] to imply that TDP-43S 
contains both regions of globularity and disorder. This is likely to be associated with 
the flexibility of TDP-43’s linker, as shown in the Kratky analysis of other multi-
domained flexible proteins [132]. The integral of the initial bell curve (up to 2.5 q(Å-
1)) represents folding with a comparable mass prediction by SAXSMoW [8] of 22.4 ± 
2.24 kDa compared to 19.1 kDa calculated from its sequence (Figure 5.6).  
 
Figure215.6 Folding of wtTDP-43S by Kratky plot analysis. The Kratky plot of the 
construct implies that the majority of protein in solution is structured as depicted 
by a bell curve between 0.0-0.25 q(Å-1). At higher q(Å-1) the I(q)q2 increases after 
q(Å-1) ~0.28 to suggest the presence of unstructured regions. The SAXSMoW 
molecular weight estimate, depicted by the shadowed area, estimated the 
molecular weight of wtTDP-43S to be 22.4 ± 2.4 kDa. 
SAXSMoW 0-0.25q(Å)  
Molecular weight 
estimation: 22.4 kDa 
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5.6 Wild-type TDP-43S ab initio modelling  
 
The wtTDP-43S SAXS curves were used as an input for the ab initio reconstruction 
program GASBOR [114]. A total of ten GASBOR models were produced, to provide a 
selection of possible solutions describing the TDP-43S structure which all could 
superimpose the wtTDP-43S 1D curve (Figure 5.7). Each model could fit the data to 
produce a valid model describing the shape of wtTDP-43S, ranging between 
2.86<  <5.44 by CRYSOL [117]. 
The individual models were pooled to incorporate all the unique structural features 
from the individual GASBOR runs to produce an average 3D model for wtTDP-43S 
(Figure 5.7).   
 
 
Figure225.7 wtTDP-43S ab initio modelling. A, GASBOR was utilised to produce 10 
individual models to represent wtTDP-43S in solution. B, Each model’s theoretical 
scattering was compared against the original 1D wtTDP-43S data and goodness of 
fit ranged between 2.86<  <5.44. C, The final model was produced by averaging 
the individual models using DAMAVER [133] to produce a representation with all 
spatial features from the individual models incorporated.   
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5.7 The incorporation of known structure (Rigid-bodies) 
 
The two independent domains of wtTDP-43S are known in the form of an NMR 
structure describing human RRM1 (PDB: 2CQG) and X-ray crystallographic model of 
mouse RRM2 (PDB id: 3D2W) [77]. These structures can be used as rigid-bodies, 
described as static structures that are considered when generating SAXS models 
from the data. The incorporation of rigid-bodies can be used to describe regions of 
known TDP-43 structure and spatial positions within the 3D solution model. 
Therefore the spatial compactness of these domains could determine whether it is 
likely for the tandem RRM domains of TDP-43S to form inter-domain interactions as 
shown in the structure of hnRNP A1 (UP1) [85]. These bridges in UP1 were 
orchestrated by Arg75 and Arg88 in RRM1 to Asp155 and Asp157 of RRM2 and are 
also predominantly conserved in the TDP-43S sequence (Chapter II, Figure 2.3 & 
2.4). Although it is worth noting that the UP1 structure is derived from X-ray 
crystallography so it may be possible that these contacts are forced by crystal 
packing.  
TDP-43S rigid-body structures were derived from the protein data bank but 
truncated to contain the residues found in the wtTDP-43 construct. The structures 
of human RRM1 (PDB id: 2CQG, residues 106-177) and mouse RRM2 (PDB id: 
3D2W, residues 193-259) without ssDNA were used as the rigid-bodies during SAXS 
analysis by BUNCH [115]. To ensure that the structure of bound RRM2 did not 
significantly alter when unbound it was superimposed against the apo structure of 
human RRM2 (PDB id: 1WF0) (Figure. 5.8). The structures superimpose well with an 
RMSD difference of 0.66 Å differing only at flexible loop regions. The rigid-body 
structures used for modelling are depicted in figure 5.9.   
 
5.8 TDP-43S rigid-body modelling 
 
The ATSAS software BUNCH [115] was employed to incorporate the RRM structures 
into a SAXS model. Amino acids not described in these structures were generated 
as a carbon alpha (Cα) trace by the simulated annealing protocol employed by the 
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software used to assign their most probable conformation. These Cα traces were 
subsequently rebuilt to include sidechains by the online program SABBAC [116] 
based on energy based scoring, whilst still preserving Cα positions. This was 
performed so that all unique residue features are considered when relating the 
model back to the experimetal data. A total of eight  PDB rigid-body models were 
generated to provide a consensus of spatial arrangement that could convincingly fit 
the original 1D data by CRYSOL (Figure 5.10). Fits ranged between    values of 
2.90<  <4.03 which could also be matched by their respective theoretical curve 
upto the q(Å-1) ~0.47 angular range to show that the 3D models are a good 
represention of the data.  A spatial consensus was achieved with a similar degree of 
domain seperation observed in all models to demonstrate that the SAXS analysis 
was concise and repeatable.  
From the average spatial arrangement RRM domains exceeded the distance viable 
for salt-bridges, electrostatic, di-sulphide, hydrogen or Van der Waal bonds to form 
showing that the RRM domains do not always interact in solution. Whether inter-
domain interaction occasionally occur between the RRM-RRM domains cannot be 
determined by an average model so was investigated further by ensemble 
optimisation methodology (EOM), described in this chapter, section 5.14.   
The best model, defined as having the lowest  2 value ( 2=2.90), could be 
superimposed into the ab initio GASBOR model to support the average solution 
structure of wtTDP-43S by two independent analytical methods (Figure 5.11). 
Interestingly the Dmax in the rigid-body models was ~75.5Å which is ~10Å below 
the Dmax estimated in the P(r) profile. The distance frequency after 75.5Å in the 
P(r) plot is negligible (Figure 5.4) to suggest that very little density exists at the 
maximum dimensions which is likely due to flailing end terminals. Note that trying 
to fit the P(r) to this cut-off results in a uninterpretable profile (Appendix 4) to 
suggest that some inter-domain distances do extend further. 
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Figure235.8 Comparison of solution and crystal RRM2 structures from human & 
mouse. The RRM2 rigid-body from mouse (Red) was ssDNA bound but 
superimposed against unbound human RRM2 (Green) with an RMSD difference of 
0.66 Å.   
 
Figure245.9 Rigid-bodies used with TDP-43S variant modelling. The rigid-bodies 
used during modelling depicting RRM1 (PDB id: 2CQG) truncated to contain 
residues 106-177 and RRM2 (PDB id: 3D2W) truncated to residues 193-259. 
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Figure255.10 Ten individual rigid-body models fit to the 1D wtTDP-43S data . The 
ten rigid-body models fitted the data up to the ~0.47 q(Å-1) range with   values of 
between 2.90-4.1.  The rigid-body models agreed on the spatial arrangement of the 
RRM domains. The average  spatial arrangement suggests that no inter-domain 
interactions occur between RRM1 and 2.  
2.
 
Figure265.11 WtTDP-43S ab initio and rigid-body model comparison. A, The rigid-
body model which best matched the data (  : 2.90) fit the 1D curve. B, mouse 
wtTDP-43S could superimpose within GASBORs’ ab initio model.   
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5.9 Rg comparisons between mutant TDP-43S 
 
Building on the success of wtTDP-43S SAXS modelling, mutant models were 
generated in order to compare structural parameters. Two disease associated 
mutations were tested, D169G and K263E, using the same data collection 
methodology and data pooling criteria as previously described for wtTDP-43S 
(Figure 5.12). The mutant 1D profiles were similar to wild-type, however, the 
concentration of the K263E variant was lower which contributed to a slight increase 
in noise at elevated q(Å-1) >0.25 ranges (Figure 5.13).  
The Guinier analysis of the data gave comparable Rg’s of 22.6 ± 0.1Å, 22.4 ± 0.1Å 
and 21.8 ± 0.1Å for D169G, K263E and wild-type TDP-43S respectively providing an 
early indication that construct sizes don’t significantly vary. The Rg calculated from 
the P(r) profile (Figure 5.14) were slightly increased calculated as 23.5 ± 0.1Å, 22.8 ± 
0.1Å and 23.3 ± 0.1Å respectively for D169G, K263E and wtTDP-43S.  
 
Figure275.12 Frames used to describe TDP-43S mutants. The elution of TDP-43S 
mutants through the size exclusion column were analysed by SAXS to yield the 
scattering intensity I(0) and radius of gyration (Rg) used to identify frames 220-231 
for pooling (as described for wild-type TDP-43S).   
 
5.10 Comparison between variant TDP-43S P(r) profiles 
 
The maximum distances were calculated at 85.5 Å for each variant though a higher 
distance frequency was located in the first peak between 20-35 Å for K263E  and 
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slightly less when approaching Dmax >60 Å (Figure 5.15). This could indicate extra 
density within one of the globular regions and a reduction in the protein population 
that extend to these lengths. A possible explanation could be that the K263E 
mutation inhibits extra flailing of the C-terminal end by forming contacts with 
RRM2, to both increase electron density at one RRM domain and reduce the 
number of interatomic distances capable of extending to the longest dimensions 
(Dmax).
 
Figure285.13 1D scattering profiles of TDP-43S variants and mutant Guinier 
approximation. A, The 1D scattering plots for wild-type, D169G and K263E TDP-43S 
variants. The 1D curves match well however the K263E mutation had a larger 
background contrast which increased its error at the higher angles q(Å-1) >0.25. B, 
The Guinier approximation of D169G resulted in an Rg of 22.6 ± 0.1Å C, for K263E 
TDP-43S an Rg of 22.3 ± 0.1 Å with qRg limits below 1.3. 
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Figure295.14 Pair-wise distribution of TDP-43S variants. The P(r) profiles of the TDP-
43S variants were normalised and plotted against each other. No significant 
differences were observed between the wild-type (red) and D169G mutated TDP-
43S (blue) profiles. The K263E TDP-43S mutant (green) profile varied in distance 
frequency at ~25 r(Å) peak and nearing Dmax.  
 
5.11 Variant folding using Kratky plots 
 
To assess protein folding differences Kratky plots were compared against variant 
and wild-type TDP-43S. The molecular weight estimates were within the 10 % 
experimental error of SAXSMoW [134] calculated at 20.6 ± 0.1, 21.4 ± 0.1 and 22.4 
± 0.1 kDa for D169G, K263E and wild-type TDP-43S respectively to suggest a similar 
structure (Figure 5.15).  
However TDP-43S constructs were all shown to deviate from the criteria described 
for  globular protein when compared through a dimensionless Kratky [110] 
(described in chapter IV). This was performed by normalising each construct to the 
I(0) and Rg of wild-type TDP-43S. The maximum peak height surpassed 
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(qRg)2I(q)/I(0) of 1.1 and didn’t peak until after the qRg range, deviating from what 
is expected for a perfectly globular species. This deviation was similar for the multi-
domained p47 phagocytic oxidase (PHOX) protein, which was shown to be 
separated by a flexible linker [110] and which is also likely to be the case for all TDP-
43S variants. 
The D169G mutant and wild-type TDP-43S had an identical overlay to indicate no 
changes. However, a narrower curve between qRg 0.0-5.5 was seen for the K263E 
mutant (Figure 5.15). This narrowing suggests that less surface area is accessible to 
the surrounding solvent, supporting the hypotheses that its C-terminal region is less 
exposed, perhaps interacting with RRM2. 
 
5.12 Variant ab initio modelling and comparison 
 
In order to compare structural differences conveyed by TDP-43S mutations, ab 
initio models were constructed as previously described for D169G and K263E 
mutated TDP-43S. All 10 models could re-fit the 1D data by CRYSOL for each 
construct with  2 minimisation ranges of between 5.77<  <8.27 and 1.74<  <2.21 
respectively for D169G and K263E (Figure 5.16, 5.17). The averaged structures as 
expected produced comparable models to the wtTDP-43S protein with no 
differences to the maximum dimensions or signs that the domains are more 
compact or elongated (Figure 5.18).  
The observed similarities between mutant and wild-type models suggest that 
mutations do not cause a global change to TDP-43S structure. The observed subtle 
differences regarding the K263E mutant P(r) profile did not seem to significantly 
affect the distribution of the average electron density of its 3D ab initio model. 
Therefore it is difficult to ascertain whether the mutation can mediate an 
interaction with the C-terminal to restrict flailing or whether noise attributed by a 
lower concentration allows the fit to deviate slightly more at higher q(Å-1) ranges 
during ab initio modelling. Due to the low resolution of SAXS, this observation 
would require further analysis by either NMR or X-ray crystallography.   
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Figure305.15 Dimensionless Kratky plots of the TDP-43S variants. The wtTDP-43S 
profile was used as a reference for the folding of both mutant variants shown in 
red. The peak height as described for ideal globular structures are depicted as a 
dashed line [110]. Profiles on the left show the D169G mutant which match the 
wtTDP-43S profile to indicate no structural changes. The right profiles depict K263E 
which contains a higher and narrower peak compared to wild-type, indicative of 
lower solvent exposure.  
 
 
  SAXSMoW 
Molecular weight 
estimation: 20.6 kDa 
  SAXSMoW 
Molecular weight 
estimation: 21.4 kDa 
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Figure315.16 Ab initio model fits of D169G TDP-43S. Each of the individual models 
derived from GASBOR (Figure 5.18) fitted the entire experimental scattering profile.
 
Figure325.17 Ab initio model fits of K263E TDP-43S. Each of the individual models 
derived from GASBOR (Figure 5.18) fitted the entire experimental scattering profile. 
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Figure335.18 Ab initio models of D169G and K263E TDP-43S. A total ten ab initio 
GASBOR models were generated for each TDP-43S variant protein A, Showing the 
individual ab initio models of the D169G and B, K263E TDP-43S mutations.  The 
averaged structures performed by DAMAVER produced C, The average electron 
distribution model of D169G and D, K263E TDP-43S.  
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5.13 Rigid-body modelling of TDP-43S variants 
 
The same rigid-bodies and modelling procedures previously described for wtTDP-
43S were performed for D169G and K263E TDP-43S to determine whether 
mutations disrupt the RRM-RRM spatial separation. The best fits based on the 
lowest  2 were  2=3.272 (Figure 5.19)  and  2=2.059 (Figure 5.20) for D169G and 
K263E mutations respectively and in both models theoretical curves could re-fit the 
experimental 1D data well, up to at least the q(Å-1) 0.45 range.    
All TDP-43S variants tested could match the RRM spatial separation of wtTDP-43S 
with the same maximum distance of 75.5Å (Figure 5.21).  Revealing that RRM 
disease mutations are unlikely to induce abnormal RRM inter-domain interactions 
and that these structures are likely conserved in solution. This implies that 
neurodegenerative disease mutations do not cause large areas of domain unfolding 
or conformational changes. Both ab initio and rigid-body models for all variants can 
superimpose to show constructs essentially share an identical global structure at 
this resolution (Figure 5.22).  
 
Figure345.19 Rigid-body model of D169G TDP-43S. The fit of the D169 TDP-43S rigid-
body against the experimental 1D curve.  
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Figure355.20 Rigid-body model of K263E TDP-43S. The fit of the K263E TDP-43S 
rigid-body against the experimental 1D curve. 
 
Figure365.21 Spatial separation of the tandem RRM domains in the TDP-43S 
constructs. The rigid-body models for TDP-43S variants consistently separate the 
RRM domains the same spatial distance apart in the average model.  
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Figure375.22 Ab initio and rigid-body fits of the TDP-43S variants. Comparisons 
between the SAXS models for A, wild-type  B, D169G and C, K263E TDP-43S . All 
models support the ab initio reconstruction and spatially arrange the RRM domains 
the same distance apart.  
 
5.14 Determining the flexibility of TDP-43 by EOM 
 
To determine the extent of TDP-43S’ flexibility as suggested by the P(r) and Kratky 
plots, EOM was employed. This technique is adapted for flexible systems and 
correctly considers that the 1D SAXS curve is comprised of different sized TDP-43S 
subpopulations. EOM attempts to match the experimental curve by changing the 
ratio of different sized models probing the entire spatial configuration until the 
theoretical scattering converges with the experimental data, as explained in  
chapter IV. 
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An ensemble consisting of 10,000 TDP-43S models with rigid-body constraints were 
generated for each variant. The results could fit the curves using two sub-
populations of structures which peaked with an Rg at ~20 Å and ~27 Å for each 
construct (Figure 5.23). The curves converged with    values of 1.92, 2.76 and 1.81 
for wild-type, D169G and K263E TDP-43S respectively indicating a good fit to the 
data as indicated (Figure 2.24).  
The results suggest that TDP-43S and mutant variants are able to elongate from ~50 
to ~90 Å in length. The fact that the histograms are predominantly generated from 
two populations suggests that there is a transition, perhaps limited by some rigidity 
in the linker to restrict the amount of intermediate protein lengths. Interestingly 
the largest contribution is from the shorter population with an Rg of ~20 Å, similar 
to UP1. From comparing the lengths of the mean structures in each population 
(used in the ensemble) the full extent of TDP-43S flexibility in solution can be 
appreciated (Figure 5.25).   This shows that the linker is able to fully elongate but 
rarely do the two domains come into contact (from models used in the converging 
populations).  
Interestingly, even the RRMs in the mean structure describing the shortest Dmax 
(~57Å) exceed the distance for inter-domain interactions to occur. Taken together 
with the features of the Kratky and P(r) plots the TDP-43S construct is flexible, but 
instead of oscillating in a smooth action the RRMs movement may be restricted by 
some rigidity of the linker, as suggested by two clear subpopulations in EOM. More 
importantly disease related mutations occurring in the TDP-43S region do not affect 
the protein’s flexibility, inter-domain interactions or global unfolding, which should 
all be reflected in the experimental curves, fits and structures of each TDP-43S 
variant. 
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Figure385.23 Ensemble optimisation methodology between TDP-43S variants. From 
The ensemble pool of structure (10,000 models), variant TDP-43S 1D profiles could 
converge using subset of these structures.  A, wild-type  B, D169G and C, K263E 
TDP-43S variants. The fit comprised of two extreme populations in regards to Rg 
and Dmax from ~20 to ~27 Å and from a maximum length of ~58 to 80 Å. Indicating 
a flexible protein with no significant differences between mutations. The 
converging fit can be seen Figure 5.24. 
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Figure395.24 EOM  converging population fit to the original TDP-43S variants 1D 
data. The fits of the converging populations shown in Figure 5.23 back to the 
original 1D data. The fits superimpose the experiemtal data well with low  2 values 
of 1.92, 2.76 and 1.81 for wild-type, D169G and K263E respectively.  
 
 
Figure405.25 The elongation of TDP-43S variants. Spatial comparison between two 
manually chosen structures from the ensemble pool but included in the final 
converging fit for all TDP-43S variants. These describe the mean population sizes at 
Dmax ~57 and ~77 Å. The compact population still orientates the RRMs of TDP-43 
outside the range for interactions to occur and at ~77 Å shows that the linker is able 
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to fully extend. Linker and terminal regions were not reconstituted and are shown 
as Cα trace. 
5.15 The secondary structure content of TDP-43S predicted by circular dichroism 
 
TDP-43S SAXS models were shown to be similar to suggest neurodegenerative 
disease mutations do not cause onset through large structural disruption. However, 
at this resolution we cannot exclude structural changes occurring at the local 
environment surrounding the mutation. Some proteins have shown that a single 
point mutation can change secondary structure with impacts on function and turn-
over.   Consider the G1015V point-mutation in human collagen alpha5(IV) chain, 
where a significant amount of secondary structure content is changed which is 
associated with disease severity of Alport syndrome [135]. 
Using CD, disease associated mutations in TDP-43S were analysed to detect 
whether there is any obvious change to their secondary structure content. CD 
measurements are most effective when measuring at the far-UV regions, 170-
180nm, to uncover unique structural features of the protein (explained in Chapter 
IV, Figure 4.3). Chlorine is a large absorber at this range so HCL and NaCl were 
replaced by phosphate buffer and NaF to maintain protein solubility, maximise CD 
signal from protein and reduce background noise.   
CD profiles were measured using protein concentrations of 0.81 mg/ml scanning 
between the 174-260 nm wavelengths (Figure 5.26). The spectra from all variants 
were comparable with errors that overlay to indicate that secondary structure is 
conserved in all constructs (Figure 5.26). To determine the secondary structure 
composition within TDP-43S the CDSSTR variable selection algorithm was utilised 
[122,124] as described in chapter IV.  
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Figure415.26  CD profile overlay of TDP-43S profiles. The profiles overlay between 
wild-type, D169G and K263E TDP-43S. Showing errors overlap to support similar 
secondary structure content.  
 
The reference set of proteins were derived from the SP175 dataset adapted for use 
with synchrotron CD data. The SP175 reference set is comprised of 71 annotated 
proteins each with a CD profile measured from 175-240 nm and a high resolution 
structure available to increase the accuracy of relating structural features back to 
the experimental profile [136].  
Secondary structure content estimates from CD by analytical algorithms should fit 
the experimental data with a normalised root mean squared deviation (NRMSD) of 
<0.1 [121]. The CDSSTR algorithm fit the full range from 175-240 nm with an NRMSD 
range of 0.11-0.14 (Table 5.1) which was improved to 0.091-0.097 when excluding 
data <190 nm (Figure 5.27). Unfortunately, secondary structures in proteins absorb 
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strongly between 175-200nm illustrated in chapter IV, figure 4.3 therefore both 
ranges were used to determine the proportion of secondary structure (Table 5.1).  
 
Figure425.27 CDSSTR fits using full and truncated profiles. The CDSSTR secondary 
structure estimation software was used to assign secondary structure content to 
TDP-43S profiles. The algorithm could fit the majority of the profiles even at the far 
UV range. The fits were judged by the normalised root mean squared deviation 
(NRMSD) (as shown in Table 5.1).  
 
CDSSTR predicted a β-sheet rich structure in all variants ranging from 38-41% and a 
low α-helix content of 6%. This is lower than expected by comparing the deposited 
RRM1 and 2 (PDB id; 2CQG and 3D2W) structures assuming no secondary structure 
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in the terminal or linker regions, which estimates 21% α-helix, 34% β-sheet, 8% 
turns and 37% disorder (Table 5.1). The CDSSTR prediction therefore 
underestimated the α-helix content by ~15% which  
 
Table35.1. Secondary structure content of TDP-43S profiles.   
TDP-43S Variant NRMSD α-Helix β-Sheet Turn Unordered 
+/- + - + - + - + - + - 
Wild-type 0.11 0.09 6% 6% 41% 39% 11% 13% 41% 41% 
K263E 0.14 0.10 6% 6% 38% 39% 13% 13% 41% 40% 
D169G 0.13 0.09 6% 6% 39% 40% 13% 13% 40% 41% 
PDB files;       
2CQG, 3D2W N/A N/A 21% 34% 8% 37.5% 
Two profiles were calculated using the full data range from 175 nm (+) and 
truncated before 190 nm (-) to 240nm.   
 
was also observed by Greenfield using this method and data <208 nm [137,138]. A 
similar trend is observed in a fragment of the periplasmic receptor protein, TolA 
where CDSSTRprovided the most accurate fit but also underestimated the α-helix 
content. The authors suggest this may be due to the flexible extensions of the 
protein absent in the TolA crystal structure [139] which may also be true of TDP-
43S. Other CD algorithms e.g. CONTIN [125], SELCON3 [126] were also used but 
could not accurately fit the data with NRMSD values in excess of 0.2 (data not 
shown). 
However the CD profiles for each TDP-43S variant could be superimposed to within 
the errors of the data, to show that the secondary structure is likely to be similar 
between all TDP-43S variants.  
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5.16 The disruption of RRM structure is an unlikely cause for TDP-43S mediated 
disease 
 
Susceptibility to thermal and chemical unfolding is a common characteristic of 
proteins involved in neurodegeneration [140–143] exemplified by ALS mutations in 
superoxide dismutase-1 (SOD1). Many of the ALS associated mutations in SOD1, 
situated throughout the structure are believed to cause structural instability by 
exposing hydrophobic regions and increasing the protein’s aggregation potential 
[143,144]. Similar aggregation is associated with protein mis-folding exemplified by 
amyloid-β In Alzheimers’ and α-synuclein in Parkinsons’ diseases [145] to suggest 
that neurodegeneration is largely associated with protein instability.  
In contrast, here using two structural solution techniques, SAXS and CD, show that 
disease mutations associated with TDP-43 RRM domains cause no change to 
structure. The RRM domains are predicted to contain most of TDP-43’s ordered 
structure but the majority of mutations occur within the disordered C-terminal 
domain [62]. It is therefore unlikely that conformational changes or unfolding 
within the structure of TDP-43 is the main cause of disease onset. This is in direct 
contrast to the mechanism described in other proteins involved in 
neurodegenerative toxicity [140–143] to suggest that other protein properties such 
as function and stability could be important disease determinants.  Therefore the 
structural stability of TDP-43S was tested using thermal denaturating assays to 
substantiate this further.  
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Chapter VI 
Approaches used to determine structural stability and 
DNA affinity of TDP-43S constructs 
 
6.1 Differential scanning fluorimetry (DSF) 
 
This technique was employed to assess the melting transitions (Tm) between TDP-
43S and its disease related mutations. This method uses a fluorescent dye which 
can be tracked by its fluorescent emission when interacting with non-polar 
environments like that of exposed hydrophobic residues [32].  
During this study the Sypro Orange™ dye was used as similarly described for other 
DSF protein unfolding experiments [33]. This is adapted for protein unfolding since 
its wavelength emission (~610 nm) when excited (~470 nm) is sequestered by 
aqueous environments so is specific to exposed hydrophobic amino acids of 
proteins in a suitable buffer. The strength of the Sypro Orange™ fluorescent signal 
is proportional to the amount of dye molecules bound to a protein, which increases 
as the protein unfolds (Figure 6.1) [34]. Since this dye binds indiscriminately it is 
essential that samples are homogeneous to avoid measuring contaminant proteins.  
Assays can be developed to test protein unfolding as a function of several 
parameters including e.g. urea, DTT, ligands, temperature or pH. Each are designed 
to unfold protein amino acid tertiary structure by disrupting bonds to cause 
unfolding. Protein stability is conferred by hydrogen, Van der Waals, disulphide and 
polar interactions which differ in number between proteins. Therefore, one is able 
to determine the stability of a protein by slowly incrementing the stress (i.e. via 
increasing concentration, acidity, temperature). Temperature was used during this 
study as it is readily repeatable and modern PCR equipment can carefully regulate 
small ˚C increments. 
The experiment required a fluorimeter capable of emitting and measuring the 
required wavelengths through a temperature range that will cause the protein to 
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unfold, typically up to ~95˚C. Experiments are generally performed using a real-time 
PCR machine since sample volumes are small and modern instruments are capable 
of slow temperature increments and tracking at these wavelengths.    
The resulting curves monitor the extent of unfolding by increases in fluorescence 
signal. It is not uncommon to observe a decline in signal after the flouresence 
peaks. This can be attributed to the removal of the dye by protein aggregation as 
shown in the DSF schematic [32] (Figure 6.1). The melting temperature from this 
curve can be obtained via the parameters of a sigmoidal Boltzmann fit or the 
plotting of its first derivatives [146].  
 
 
 
 
Figure436.1 Typical features of a DSF curve. Folded protein is incubated with Sypro 
orange at low temperature and exposed hydrophobic regions dequench the dye to 
become the baseline. During unfolding a higher proportion of these residues will 
become exposed leading to increased signal and eventually diminishes as the dye is 
removed by protein aggregation. 
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6.2 Aromatic tracking 
 
Aromatic tracking monitors the natural fluorescence of aromatic amino acids local 
environment and does not require the use of a secondary signalling molecule. Of 
the four aromatic residues only tryptophan and tyrosine and in rare occasions 
phenylalanine emit a signal strong enough to be used during analysis. The intrinsic 
fluorescent properties of aromatic residues have been used since the mid 1900s to 
track changes between aromatic local environments during protein unfolding 
[147,148].  
During this study only the signal from tryptophan and tyrosines were measured 
since phenylalanine requires a different excitation wavelength (~240 nm) [149]. The 
excitation and emission wavelengths of tryptophan and tyrosine are ~280 and 308-
355 nm respectively depending on the local environment [150].  This is usually 
empirically derived through scanning between these wavelengths.   
The experimental requirements are the same as DSF, although many commercial 
real-time PCR machines do not contain the correct fluorescent filters, so cannot be 
used to achieve an increasing temperature range. To overcome this, protein 
samples can be pre-heated at various temperatures, spanning the proteins 
unfolding transition which can then be cooled and tested in a standard fluorimeter 
capable of measuring at these wavelengths. 
Unlike DSF the fluorescent signal need not necessarily increase, as aromatics are 
sensitive and dependent on the local environment as well as aqueous sequestering 
[150]. However, one would expect a significant signal change when the protein 
unfolds, or changes conformation involving segments that contain one or several of 
these residues. 
 
6.3 Isothermal Titration Calorimetry (ITC) 
 
This technique is regarded as the ‘gold-standard’ in determining ligand affinity (Kd), 
entropy (S) and enthalphy (H)  values [151–153]. 
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ITC exploits the exchange of heat between the ligand, protein and local 
environment generated during an interaction. ITC specifically measures the 
temperature of the local closed environment and determines how much energy 
(calories) is needed to return the cell’s temperature to the original base value. An 
accurate measurement of this interaction is related to the kinetic parameters in the 
following relationship (Equation 6.1);    
 
                 
 
(Equation 6.1) 
Where   is the universal gas constant (8.314 x 10-3 kJ mol-1K-1),   represents the 
time, Kd the single-site binding constant (M),     the heat of binding (K) and     
the entropy (J/K). The Kd parameter is dependent upon the ligand and active 
macromolecule concentration, which in a 1:1 stoichiometry can be explained by 
(Equation 6.2); 
     
    
      
 
(Equation 6.2) 
Where is the concentration of macromolecule and   the ligand.  
A carefully recorded heat exchange through ligand titration can be plotted, typically 
as calories/S-1 plotted Vs time. These peak values can be normalised against the 
protein concentration to generate an integrated heats plot (kCal/mole of ligand Vs 
protein concentration). A least squares regression analysis of this data with known 
molar ratios can give rise to the components required to determine the enthalpy, 
stoichiometry and binding constants as described in the schematic (Figure 6.2)  
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Figure446.2 ITC heat exchange plots. The left plot depicts the raw data representing 
a series of individual ligand-protein heat exchanges. The curve measuring this series 
diminishing signal due to protein saturation is plotted as the integrated heat plot 
(right) which with known ligand and macromolecular concentrations can yield the 
H, Kd and stoichiometry from the curves parameters. 
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Chapter VII 
The thermal-stability, half-life and single stranded 
DNA affinity of TDP-43S mutations  
 
7.1 Rationale for testing mutant mediated stability 
 
The conclusions made from SAXS modelling and CD spectra suggest disease-
associated mutations in TDP-43S do not cause a significant change to structure in 
terms of RRM spatial arrangements, secondary structure or unfolding. Therefore 
RRM mutant mediated toxicity is unlikely to arise through large structural changes 
as observed in other neurodegenerative disease related proteins [141,143]. 
However the nucleic acid binding function was tested to ensure that RRM function 
is still intact.  
Auto-regulatory disease models show onset can occur through an increase in 
cytosolic TDP-43 and/or loss of nuclear function [42]. The fact many C-terminal 
disease related mutations correlate with increasing cytosolic levels and half-life 
supports that in vivo protein stability is a real indicator of neurodegenerative 
toxicity. Interestingly this feature may relate to TDP-43 RRM disease mutations via a 
gain in structural stability. This has been correlated with an increase in thermal-
stability by mutations in pseudo-barnase and lysozyme proteins with enhanced 
cellular longevity [91–93].  
7.2 Thermal-stability of TDP-43S variants by DSF 
 
The thermal-stability of TDP-43S and mutant variants were tested using differential 
scanning flourimetry (DSF) scanning temperatures between 15-95˚C to cover both 
folded and unfolded states. Temperature increases were set at a steady 1.2˚C/min-1 
increments so that a careful recording of temperature related fluorescence could 
be monitored during protein unfolding. Preliminary experiments found that a final 
protein concentration of 0.6mg/ml and 10x concentration of Sypro Orange™ dye 
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were sufficient to monitor TDP-43S unfolding. The blank without protein shows that 
the dye and buffer doesn’t contribute to the fluorescent signal throughout this 
temperature range (Appendix 5) to show that the fluorescent signal is dependent 
on protein unfolding.  
To increase accuracy, seven repeats were measured for each TDP-43S variant and 
averaged to include the standard deviation of the data (Figure 7.1). The unfolding 
transition monitored by the fluorescent signal of TDP-43S represents that of a 
typical folded protein [154] where a low fluorescent baseline is maintained until the 
protein begins to expose previously inaccessible hydrophobic residues during 
thermal-denaturation. The difference in peak heights between TDP-43S variants 
represent varying degrees of aggregation that typically tend to increase at elevated 
temperatures, as described [154].  
The melting temperatures obtained from the first derivative plot (Figure 7.2) 
calculated for  wtTDP-43S was 50.9 ± 0.2˚C and compared well to similar 
measurements previously determined by circular dichroism (49.7 ± 0.9˚C) [77]. 
Interestingly melting temperatures for both disease related mutations increased 
the Tm to 55.8 ± 0.2˚C and 51.9 ± 0.4˚C respectively for the D169g and K263E 
mutations (Figure 7.2) showing a gain in thermal-stability. 
 
7.3 Thermal-stability of TDP-43S variants by aromatics fluorescent tracking 
 
To verify this finding melting temperatures were again calculated using an 
independent method, relying on the natural fluorescence of TDP-43’s aromatic 
residues. The fluorescent emissions from these residues are sensitive to their 
surrounding environment and as such can be used to track changes to their local 
environment during thermal-unfolding.  The most intense fluorescent signals are 
achieved through tryptophan and tyrosine as described in chapter VI   which are in 
sufficient quantities to enable the tracking of fluorescent signal (Figure 7.3). These 
aromatics are predominately located on RRM1 including W113, W173, Y122 and 
Y155 though RRM2 can contribute through Y214. The excitation and emission 
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wavelengths used were calculated by scanning the light spectrum between 260-
400nm, which peaked at 280 and 340 nm respectively.  
The fluorimeter capable of tracking these wavelengths was un-heated, therefore 
samples were pre-treated for 5 minutes at 2˚C intervals between the 37-65˚C 
temperature range to cover the unfolding transitions identified by DSF. A total of six 
repeats were performed for each TDP-43S variant and averaged to obtain the 
standard deviations (Figure 7.4). From the curve, two features concerning 
fluorescent signal strength were observed in the form of an initial decline at 45˚C 
and a rise to above the baseline at 50˚C suggesting that unfolding involves  a two-
state mechanism. The first state of quenching at ~45°C indicates a change in the 
aromatics local environment likely due to unfolding or a conformational change. 
This feature occurs at the same temperature in all profiles to suggest that at least 
some folding is similar initially. 
Because of these two features an accurate sigmoidal curve could not be assigned to 
the raw data therefore curves were normalised to the trough after the initial 
decline in signal (Figure 7.5). The data were fitted using a Boltzmann curve to 
calculate the Tm’s as  52.5 ± 0.9°C, 55.8 ± 0.8°C and 58.7 ± 2.8°C with standard 
deviation respectively for wild-type, K263E and D169G  to coincide with the 
observations from DSF.  The finding that both methods independently arrived at 
the same conclusions provide convincing evidence that TDP-43S disease associated 
mutants mediate a gain in thermal-stability. Interestingly mutant mediated stability 
increases of just 2.4˚C in pseudo-barnase led to 14% more protein in the periplasm 
in prokaryotes [93] to suggest that an increase of up to ~5˚C may have a significant 
effect on cytosolic levels of TDP-43, assuming a similar trend. 
 
 
 
92 
 
 
Figure457.1 Differential scanning fluorimetry of mouse wtTDP-43S and mutant 
variants. Each construct had an average melting curve plotted from 7 individual 
runs showing standard deviation.  
 
Figure467.2 TDP-43S variant melting temperatures calculated from first derivatives. 
The melting temperatures were calculated from the first derivative of the plots of 
the average melt curves (Figure 7.1). The peak corresponds to the melting 
temperature of the variant, which calculated a melting temperature of 50.9 ± 0.2 
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°C, 51.9 ± 0.9 °C and 55.8 ± 0.8 °C for wild-type, K263E and D169G TDP-43S 
respectively. 
 
 
Figure477.3 Location of aromatic residues within the RRM structures. The SAXS 
rigid-bodies of A, RRM1 and B, RRM2 with structural positions of aromatic residues 
(Orange; Tryptophan and Yellow; Tyrosine) and mutation locations (Red). 
 
Figure487.4 Aromatic fluorescent tracking of TDP-43S variants during thermal 
degradation. The thermal unfolding of TDP-43S variants were traced using the 
fluorescent signal of aromatic residues, depicted in Figure 7.3. The unfolding 
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indicated a two state unfolding reaction where aromatics are quenched at 45°C 
then dequench ~55°C.  
 
 
Figure497.5 Normalised aromatic dequenching profile of TDP-43S variants. The 
aromatic dequenching curve was normalised to % unfolding, assuming 65°C is 100% 
and 45°C was 0%, the melting transitions were determined by a Boltzmann fit which 
calculated 52.5 ± 0.9°C, 55.8 ± 0.8°C and 58.7 ± 2.8°C for wild-type, K263E and 
D169G respectively. 
 
7.4 In vivo half-life of TDP-43 mutations in a Neuro-2a cell-line 
 
Since it was shown that disease related mutations occurring within the TDP-43S 
region increase thermal-stability, it was important to directly relate this to in vivo 
half-life as suggested in other proteins. This was critical to show that RRM related 
mutations also mimic the cellular longevity inferred from C-terminal disease 
mutations [56,57] adding to the growing trend of mutant mediated cellular stability.  
To this end a collaboration between members of Yamanaka’s group in Japan tested 
the half-life of native, D169G and K263E within the mouse neuroblastoma Neuro2a 
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cell-line using full length human TDP-43 (plasmids provided by the MBG, Liverpool). 
This cell-line was chosen since it has been used previously to model disease related 
proteins to human neurotoxicity [155–158]. Protein half-lifes were tested using the 
established pulse-chase methodology as described [56]. 
Levels of newly synthesised TDP-43 were non-invasively labelled with L-
azidohomoalanine (AHA) (the pulse) and diminishing levels of the label were 
recorded over a 24 hour period using the natural expression of un-labelled TDP-43S 
(the chase).  
Human TDP-43 variant half-lifes were determined as 9.7 ± 0.38, 22.1 ± 1.36 and 
18.4 ± 0.93 hours respectively for wild-type, D169G  and K263E mutations.  The 
most thermally stable, D169G increased half-life by ~12.4˚C and K263E by ~8.7˚C 
above the wild-type species. The extent of thermal-stability established in DSF and 
aromatic fluorescent techniques therefore positively correlated with the longevity 
in these cells.  This is the first example of thermal-stability increases being 
associated with increased cellular half-life of TDP-43. Thus establishing a possible 
cause and effect for disease onset. 
 
Figure507.6 Half-life increases of TDP-43S mutations in cultured cells. The half-life 
of TDP-43 proteins were measured by Professor Yamanka’s group, Japan using 
cultured Neuro-2a cells. The drop in the level of protein (%) correlates to the half-
life inside the cell as previously performed [56]. 
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7.5 Is TDP-3S stability associated with aggregation propensity? 
 
The increase in stability identified by DSF coincides with aggregation observed by a 
reduction in fluorescent peak height (Figure 7.1). This reduction coincided with the 
extent of thermal stability, with the largest decline in signal occurring from D169G 
(a mutation which has not been shown to change a function or property of TDP-43).  
To establish whether mutations affect the aggregation potential of TDP-43S, SAXS 
methodology was used to determine the radius of gyration by static SAXS 
measurements at two temperatures. This data was collected at the Barkla 
laboratory in the University of Liverpool, measurements were averaged from 3 x 20 
minute exposures using 3mg/ml protein concentration at a sample-detector 
distance of 125 cm. The custom made cell for these experiments used 30um Kapton 
windows and a cell thickness of 1.2 mm. As these were static measurements, 
protein aggregation cannot be removed before analysis by HPLC and therefore 
contribute to the analysis, especially in the calculated Rg value.  Using the less 
intense home X-ray source meant proteins had to be exposed for at least 60 
minutes to collect a sufficient amount of data. This caused radiation damage and 
precipitation even at 20˚C. Therefore the addition of 20mM DTT was included to 
minimise oxidative damage and improve solubility. Data from three 20 minute 
sessions were pooled and averaged for TDP-43S variants at 20˚C and 40 ˚C and 
produced the 1D curves  observed in Figure 7.7. 
The Guinier estimates using the same regions produced Rg values with standard 
error at 20˚C of 25.8 ± 5.3, 23.3 ± 5.2 and 25.0 ± 3.9Å (Figure 7.8) which  rose to 
40.1 ± 1.9Å, 25.7 ± 5.5Å and 24.5 ± 5.1Å  at 40°C (Figure 7.9) respectively for wild-
type, K263E and D169G. The initial static measurement may have included some 
aggregation leading to a slightly higher Rg compared to the HPLC-coupled data 
obtained at Soleil. The Rg between mutations are comparable at both temperatures 
but wild-type increased significantly by ~15 Å which was attributed with an increase 
in aggregation. 
This suggests that stability increases conferred by the disease associated mutations 
are independent from aggregate formation and are therefore likely mediated by 
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interactions within the monomeric structure. This finding suggests that mutations 
do not increase the aggregation potential of TDP-43 and may in fact decrease its 
likelihood. This supports previous observations shown in rodent models where 
neuron degeneration is observed without the formation of aggregates or inclusions 
[50,51] though further work is needed to assess whether this is true of the full 
length protein in a suitable in vivo model.   
 
Figure517.7 Raw 1D SAXS data at 20˚C and 40˚C. The 1D SAXS curves of Wild-type, 
K263E and D169G. A, Tested at 20 ˚C and B, 40 ˚C using the in-house X-ray source in 
the Barkla laboratory at the University of Liverpool. 
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Figure527.8 Guinier regions of wild-type and mutant TDP-43S constructs at 
20°C.The linear Guinier regions were calculated from the filled circles, which were 
within the recommended qRg region limits <1.3. The Rg was calculated as 25.8 ± 
5.3, 23.3 ± 5.2 and 25.0 ± 3.9Å respectfully for wild-type, K263E and D169G. Points 
used for Guinier region (filled black) were 33-58, 33-61 and  33-58 for wild-type, 
K263E and D169G respectively. 
 
Figure537.9 Guinier regions of wild-type and mutant TDP-43S constructs at 40°C. 
The linear Guinier regions were calculated from the filled circles, which were within 
the recommended qRg region of <1.3, except wild-type which was <2.0. The Rg was 
calculated as 40.1 ± 1.9Å, 25.7 ± 5.5Å and 24.5 ± 5.1Å  at 40°C respectfully for wild-
type, K263E and D169G. Points used for Guinier region (filled black) were 31-58, 31-
58 and 31-58 for wild-type, K263E and D169G respectively. 
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7.6 Disease mutations and DNA affinity 
 
In the proposed ‘gain of auto-regulation’ model by Lees et. al. 2012, loss of nuclear 
function is attributed to neurotoxicity. a contributor to disease onset is caused 
through a loss of nuclear TDP-43 function. Since each described role for TDP-43 
requires nucleic acid binding, a reduction in RNA/DNA binding affinity is likely to 
affect its regulatory, splicing and transport function which could relate to neuro 
degeneration by inhibiting function [42]. Therefore to determine whether TDP-43S 
mutations can affect TDP-43 nucleic acid binding its affinity to single stranded DNA 
was calculated and compared against disease mutations by isothermal titration 
calorimetry as described in chapter VI.  
The stoichiometry of TDP-43 has already been suggested as 1:1 with biotinylated 
(TG)6 using a high through-put non radiometric assay [88]. Gel filtration with 
wtTDP-43S and excess ss(TG)8 also only eluted as one protein peak to suggest that a 
single TDP-43S protein is involved in the interaction (Appendix 6). Because 
functional TDP-43 levels could be lost due to aggregation (observed in the cell after 
experimentation) this stoichiometry was used to determine the amount of 
functional protein and calculate its affinity. These values could also be compared 
for accuracy against previously determined Kd affinity values for TDP-43S 
determined for similar ss(TG)6 using nitrocellulose membranes  [77].  Since single 
stranded DNA is highly soluble its concentration was kept constant throughout the 
analysis 
7.7 TDP-43S ITC affinity parameters 
 
The ITC experiment was analysed using Origin 8.6 software integrated with the 
MicroCal200 ITC instrument. Curve fitting could only converge with the integrated 
heats plot when using a single binding site curve (Figure 7.10) to indicate a single 
binding site for TDP-43S. The concentration of ligand was 60 M and the estimated 
protein concentrations for wild-type, D169G and K263E were calculated as 4.2 M, 
2.6 M and 2.0 M respectively to reflect the 1:1 stoichiometry.  
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The ITC results calculated the Kd affinity to (TG)8 ssDNA  as  76.5 ± 14 nM, 105 ± 29 
nM and 467 ± 98 nM for wild-type, D169G and K263E TDP-43S respectively. The 
values for wild-type and D169G were comparable to the affinity previously 
calculated using nitro cellulose assays at  Kd  89.3 ± 19.3 nM to (TG)6 ssDNA [77]. In 
contrast, the K263E mutant bound fourfold weaker to suggest that this mutation 
has a detrimental effect on the binding to ssDNA. This may be due to an interaction 
occuring at or near to the nucleic acid binding site, as proposed during SAXS 
analysis of the protein (chapter V).  
 
 
 
 
Figure547.10 Isothermal titration calorimetry results of variant TDP-43S. The ITC 
results show the values of Kd affinity for wtTDP-43S (left), d169gTDP-43S (middle) 
and k263eTDP-43S (right). The Kd values illustrated in the table below show that 
‘wtTDP-43S’ and ‘d169GTDP-43s’ affinities are comparable whilst the ‘k263eTDP-
43S’  mutation is considerably higher which may highlight ligand binding 
dysfunction. 
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7.8 Neuro-degenerative RRM disease mutations increase structural stability and 
cellular half-life 
 
Two independent thermal stability methods demonstrate TDP-43 RRM associated 
disease mutations increase TDP-43S thermal stability by up to 5°C that coincide 
with cellular longevity similar to observations determined in other protein species 
[91–93]. This was shown to be mediated without enhancing the constructs 
aggregation propensity suggesting that the stability is inferred from interactions 
occurring within the monomeric subunit. The FTLD-U mutation K263E also 
perturbed TDP-43S’ affinity to single stranded TG repeated DNA when a 1:1 
stoichiometry was assumed provided two properties that may enhance toxicity 
during disease.  
The ALS associated mutant D169G had the largest resistance to thermal unfolding.  
Asp169 is located on loop 6 of the RRM1 structure separating α-helix 2 and β-strand 
4 with potential hydrogen bond interactions with the side chains of Lys114 and 
Thr115 as represented in Chapter II, Figure 2.2. The substitution of acidic aspartate 
for non-polar glycine at this position would abrogate these bonds but may facilitate 
a tighter association of loop 6 with the hydrophobic inner core and orchestrate the 
observed increase in stability. This may be orchestrated by the closest hydrophobic 
residue, L120, situated within the first α-helix, which is separated by 8.8 Å from 
G169 in the human NMR structure of RRM1 (Figure 7.11). This residue is poised 
towards the hydrophobic core of RRM1 and may provide an anchor to stabilise the 
flexible loop where G169 is situated to confer the stability increase. This change is 
similar to the substitution occurring within the human Pin1 WW domain where the 
N30G mutant situated on a connective loop increased the thermal stability of the 
domain by a comparable 6.4 °C. This was thought to be due to an improved loop 
formation [159] which is similar to our explanation for D169G stability increases in 
TDP-43. It is possible that this interaction is formed during partial unfolding shown 
by the aromatic trace at 45˚C which may arise through movement of W173 and 
W113 that are close to the D169G position in the NMR RRM1 structure (PDB id; 
2CQG) (Figure 7.3).  
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Figure557.11 Additional interactions which may form due to the D169G mutation. 
The D169G mutation and other hydrophobic residues within the RRM1 structure. A, 
Schematic of the hydrophobic residues within RRM1. B, The PDB structure of 
Human RRM1 solved by NMR and C, the positions of the hydrophobic residues and 
the closest residue situated in the core of RRM1 to G169. Performed using PyMol 
(http://pymol.com). 
 
The K263E mutant increased thermal stability by ~1-3°C and is close to the nucleic 
acid binding site. The polarity change from positive Lys to negative Glu may aid in 
forming electrostatic interactions to local positive residues located near to the 
nucleic acid binding interface restricting nucleic acid access and increasing stability 
by increasing the number of bonds (Figure 7.12). The K263 residue is also involved 
with forming direct interactions when both RRM domains interact with ssRNA as 
shown in a bound NMR structure of human TDP-43S [160]. This suggests that 
mutating this residue is therefore likely to affect nucleic acid affinity by reducing 
the amount of bonds able to form between TDP-43S and nucleic acids. However as 
this residue is only 1/25 of the total residues involved in this interaction and 1/9 of 
those occuring in the RRM2. It seems strange that removing this one interaction 
would cause such a large change (four-fold difference) to affinity. It was 
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demonstrated that mutating Lys 263 to Ala only caused a minor change to affinity 
(using GUGUGAAUGAAU RNA) from a Kd of 22.6 ± 4.3 to 35.6 ± 7.9 nm [160].  
Therefore a mechanism whereby the binding pocket is partially blocked would 
provide a better explanation for these differences.    
 
 
 
Figure567.12 Location of K263E mutation and possible charge effects.  The NMR 
structure of RRM2, truncated to residues 193-265 (PDB id: 1WF0), was aligned with 
the ssDNA from mouse RRM2 (PDB id: 3D2W). This shows A, the location of E263, 
which is situated on a flexible region close to the DNA binding region. The charge 
affects using vacuum electrostatics shows that B, the K263 residue confers a 
positive charge that reverses to negative when mutated to E263 as shown in C. This 
may form polar interactions across the binding pocket to restrict DNA access.  
 
This is likely due to E263 forming an interaction directly with the RNP regions of the 
β-core or surrounding residues to abrogate DNA contacts or restrict ligand access.  
This extra interaction may also confer this slight increase in thermal-stability 
observed during the thermal-stability assays.  However high resolution techniques 
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are required to accurately locate this interaction and deduce how unfolding and 
DNA binding are restricted. 
Recent studies using primary rat neurons correlated disease symptoms best with an 
increase in cytoplasmic TDP-43 [46]. The results here suggest that D169G and 
K263E like C-terminal mutations may cause an increase in TDP-43 cytosolic levels 
that are correlated with disease onset. Here it is shown for the first time that 
structural stability concerning the RRM-RRM region could be a potential cause for 
increasing cellular half-life. The finding that mutations outside of the C-terminal 
domain confer cellular stability suggests that onset can occur independent of 
function. This is supported by the limited amount of RRM-RRM mutations related to 
disease and the finding that D169G did not cause a change to structure or binding 
affinity. The K263E mutation may cause onset through a perturbed DNA/RNA 
binding function however this is likely to be the only mutation that this applies to, 
since negative residue substitutions are rare, only observed in 4/40 identified 
mutant point-mutation locations and all are situated away from the RRM regions to 
suggest that their involvement with RRM function is unlikely.   
Stability increases have been associated with a gain in resistance to ubiquitinated 
degradation. The fact neurodegeneration can be associated with impaired 
components of the ubiquination degradation pathways [72,73] supports this 
hypothesis. Therefore a build-up of cytosolic protein could be commensurate of 
toxicity. Simple stability increases may provide added pressure and overwhelm the 
degradation machinery causing disease onset perhaps as described by the loss of 
auto-regulation model (chapter I, Figure 1.1). Providing a common path to describe 
disease onset conferred by both RRM and C-terminal disease related mutations. 
The fact that these regions perform different functions in the protein also detract 
from a loss of function as a common trend to describe disease onset. 
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Chapter VIII  
DNA Binding Protein in Starved Cells (DPS) and DNA 
protection during stress. 
 
8.1 Introduction to DPS  
 
The E.coli stress response is reliant on protein cascades that are regulated by a few 
stress related signalling factors e.g. RpoS and OxyR that regulate multi-functional 
proteins to sequester potentially harmful substances during stress. Prokaryotes 
dedicate a significant amount of energy into protecting susceptible biologically 
important molecules such as DNA by restricting access to mutagens, nuclease 
cleavages and oxidative damage. In prokaryotes this is commonly facilitated by the 
‘DNA binding protein in starved cells’ commonly known as DPS identified in E.coli by 
Almiron in 1992 [161]. The protein is over-expressed during a variety of stress 
related pathways and forms large dodecameric complexes, able to sequester 
reactive oxygen species using catalase and ferritin-like activity.  
8.2 RpoS and OxyR E.coli stress response 
 
Prokaryotes are well adapted for efficient stress responses that are often 
encompassing to confer resistance to a variety of stress causes. For example, the 
stress response to  starvation also provides resistance to oxidative, elevated 
temperature and pH stressors [162].  This is partly due to the multi-functional 
proteins that are expressed during stress and the specificity of the stress specific 
sigma factors that regulate them. The stress responses in E.coli are predominately 
orchestrated by the stationary/stress related sigma factor ‘RNA polymerase sigma 
S’ (RpoS) or ‘oxidative stress regulator’ (OxyR) responsible for DPS expression 
during starvation and oxidative damage respectively [163]. These paths are 
mutually exclusive [163,164] and regulate by direct and indirect methods a large 
proportion of the E.coli’s genome with RpoS alone estimated to regulate ~10% 
[165]. The expression of these activators are raised in short regulatory paths [166] 
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to respond rapidly to environmental changes by stress sensing signalling molecules 
for example guanosine tetraphosphate ((p)ppGpp) responsible for activating RpoS 
expression during carbon shortages [162,165].   
 
8.3 Importance of DNA binding protein in starved cells 
 
E.coli DPS has homologues in many prokaryotic systems. The closest conserved to 
E.coli with known structure are depicted in Figure 8.1. DPS is integral to the stress 
response as demonstrated by the correlation between cellular survival and the 
knock-down of functional DPS during oxidative insult [161]. During stress DPS is the 
most abundantly expressed nucleoid associated protein, which reflects the extent 
prokaryotes rely on the protein during potentially toxic conditions [167]. This is 
unsurprising, considering the range of stress limiting functions and the conservation 
of DPS between prokaryote and archaea species [168]. These functions aim to 
remove potentially dangerous species, shield vulnerable nucleic acid targets and 
may regulate some protein expression.      
8.4 DPS function during DNA protection 
 
DPS is one of the main driving forces of DNA protection in E. coli and 
indiscriminately protects DNA from nuclease access by binding and condensing DNA 
within DPS aggregates [161]. DPS-DNA complexes are highly stable and able to 
resist heat-shock of >100°C  and prolonged heating at ~65°C [161]. The mode of this 
protection is orchestrated by the self-aggregation propensity of DPS enhanced in 
the presence of DNA [169,170]. The mode of DPS self-aggregation is thought to be 
largely mediated by these interactions, since DNA is bound before DPS dodecamers 
aggregate, shown by atomic force microscopy [169]. This self-aggregation 
eventually form crystal plates [170] which has led to several solved DPS 
crystallographic structures in a variety of prokaryote species (Figure 8.2).  
The DNA binding is largely dependent on the positively charged N-terminal lysines 
(Figure. 8.1) [169]. The removal of lys5, lys8 and lys10 by truncating the first 18 
107 
 
residues abolishes the DNA binding capacity, as shown in E.coli. The absence of this 
extended region generally coincides with a loss of DNA binding as observed for DPS 
homologs: Dlp-1, Dlp-2 and Ferritin from B. anthraci and L. innocua,  respectively 
[171,172]. The structure of non-DNA binding DPS are structurally conserved to that 
in E.coli, except for a truncated N-terminal (Figure 8.2). This suggests that binding is 
not facilitated by surface structures or charge, as previously described for non-DNA 
binding DPS in A. tumefaciens [173].  
Interestingly DNA binding can occur in rare cases without the N-terminal as shown 
through M. smegmatis and H. pylori where DPS homologues bind DNA through 
different regions. The M. smegmatis DPS binds DNA using similarly spaced lysines 
on its extended C-terminal [174] whereas the DPS homolog ‘Neutrophil-activating 
protein’ from H. pylori (HP-NAP) has adapted to bind DNA through rare positively 
charged regions on the surface of its dodecamer  [175].    
Though the N-terminal is commonly required to bind DNA it isn’t necessary for cell 
survival, as shown through oxidative toxicity between native and N-terminally 
cleaved E. coli DPS  in both an in vitro and in vivo setting [169]. The catalase and 
ferroxidase like roles of DPS are therefore sufficient in alleviating the danger from 
reactive oxygen. It is worth note that shielding DNA may protect the cell from 
prolonged stress and other stress inducing factors such as temperature, since the 
DNA:DPS complex is especially stable (up to 100 ˚C) [161]. 
 
 
108 
 
 
Figure578.1 DPS sequence homology alignment between prokaryotes. A selection 
of PDB deposited DPS proteins with highest sequence similarity to E. coli. The 
alignment was performed by ClustalOmega [84] using its colour code (Appendix 4). 
The level of conservation is also illustrated in the bar ranging from fully conserved 
(*) to unconserved (-). The three N-terminal lysines important in DPS:DNA complex 
assembly are shown in the red box [169]. The black box shows residues important 
in the ferroxidase-like centres [176]. Prokaryotes sequences used are from the 
following organisms;  Myobacterium smegmatis, Yersinia pestis, Escherichia coli, 
Salmonella enterica, Brucella melitensis and Agrobacterium tumefaciens. 
 
8.5 Iron store & ferritin-like activity 
 
DPS is adapted to facilitate an alternate pathway involving iron and ferroxidase-like 
sites to avoid the accumulation of mutagenic reactive oxygen species.  Iron is an 
important element in prokaryotes used by proteins to fulfil a variety of important 
biological processes e.g. for generating energy in the Tricarboxylic Acid Cycle (TCA) 
[177] and DNA synthesis [178].  Unfortunately, excess free iron can undergo 
uncontrolled oxidation, when coupled to elevated levels of      iron can produce 
    radicals through the fenton reaction (Equation 8.1) to cause oxidative damage 
to susceptible DNA and proteins.  
To avoid this, organisms produce ferritin which through ferroxidase activity 
facilitates the safe oxidation of      to      by molecular oxygen to avoid the 
accumulation of free radicals as described (equation 8.2) [179]. The DPS dodecamer 
facilitates this role but favours      instead of    which not only removes oxidised 
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iron but also diminishes total      levels (Equation 8.3.) [180,181]. The preference 
of     by DPS as an oxidant owes to its ferritin-like description.  
The 24 Fe3+ loaded DPS can also sequester       into harmless hydrogen and 
oxygen meaning that DPS is also described as having a catalase-like activity [180] 
(Equation 8.4). To provide a dual-function to avoid the accumulation of reactive 
oxygen species. E.coli DPS can store up to ~400 iron ions within its cavity which can 
be mobilised when reduced like iron in ferritin [182]. Iron storage is largely fulfilled 
by ferritins with bacterial ferritinA alone storing 50% of total iron during logarithmic 
and early stationary phase [183]. However it is worth note that given DPS’ 
abundance during stress a significant amount of iron could be stored by DPS and 
under prolonged stress this responsibility may be more reliant in cells.  
Fenton Reaction  
    +       
  +        (Equation 8.1) 
 
Common ferritin ferroxidase activity 
                       (Equation 8.2) 
 
DPS ferritin-like activity  
                      -    
  (Equation 8.3) 
 
DPS catalase-like activity  
                (Equation 8.4) 
 
8.6 Gene regulation 
 
DPS has also been postulated to control protein expression. Evidence of this has not 
advanced much since DPSs’ first discovery in E.coli [161] where null mutants had an 
altered 2D gel electrophoretic expressed protein profile compared to the wild type 
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strain. Since the only difference was the knock-down of DPS the authors suggest 
that DPS may in-directly regulate other proteins. In a 2011 review, authors suggest 
that DPS may regulate expression given its similar pleiotropic profile to histone-like 
proteins when knocked down [184] which have been attributed with a regulatory 
role in gene expression. However without a direct link this role for DPS is still under 
debate. 
8.7 DPS structure 
 
The multi-functions of DPS are orchestrated by its structural adaptions. The dps 
gene encodes a protein of 167 amino acids (18.7 kDa) in E.coli. The protein 
monomer consists of four anti-parallel α-helices that interact to form a functional 
dodecamer structure consisting of 12 DPS monomers arranged as a hollow sphere 
spanning ~90Å in diameter and ~40Å at its cavity.  This arrangement including 
secondary structure is conserved between prokaryotes (Figure 8.2). The cavity acts 
as the iron store and contains the ferroxidase centres which are generated through 
interacting monomers (Figure 8.3) [180,181]. This cavity is accessible to the 
surroundings by two pore types each with three-fold symmetry. The N-terminal 
interface created by DPS monomers form the ferritin-like pore used for iron access 
and lined with negative residues to facilitate iron transfer [176]. The other pore is 
generated from monomeric C-terminals and is unique to DPS, this pore has not yet 
been attributed to any function and is highly variable between different organisms. 
The internal cavity has conserved residues at H51, H63, D78, E82 and W52 near the 
ferroxidase centre that are important in forming interactions with ferrous iron 
[176]. A total of 24 ferrous iron sites exist within the cavity constituting 12 dinuclear 
ferroxidase centres, containing both high and low affinity iron sites (Figure 8.2).   
Except for the DPS homolog neutrophil-activating protein from H. pylori (HP-NAP), 
the DPS DNA binding function is also unique as the surface of the complex bears no 
resemblance to any known DNA/RNA binding motifs and is predominantly negative 
or neutral, apart from the flexible N-terminal regions, as judged through vacuum 
electrostatics (Figure 8.3). The current hypothesis is that DNA is threaded through 
holes generated between interacting DPS protein complexes during self-
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aggregation [185]. These gaps are lined with the extended N-terminal ends from 
interacting dodecamers each contributing nine functionally important lysines to 
create a positive pocket to interact with DNA [169,185].  The indiscriminate 
interaction of DNA is thought to be achieved through Mg2+ bridging coupled with 
the N-terminal lysines, as judged through co-crystallisation studies with varying 
concentrations of Mg2+ and EDTA [169,186].  It is worth note that the N-terminals in 
all DNA binding DPS complexes are non-visible in the electronic density which 
suggests that they are flexible. 
 
 
 
 
 
 
Figure588.2 Structual conservation of DPS and ferroxidase-like sites from E.coli DPS. 
A, The prokaryote DPS dodecamers are structurally conserved for; M. smegmatis 
(green, PDB id: 1VE1), Y. pestis (white, PDB id: 4DYU), E.coli (black, PDB id: 1F30), S. 
enterica (yellow, PDB id: 3AK8), B. melitensis (blue, PDB id: 3GE4) and A. 
temefaciens (purple, PDB id: 109R). B, The ferroxidase centres of E.coli showing the 
high affinity (red) and low affinity (orange) iron binding sites generated from two 
monomers shown in (yellow) and (light green). 
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Figure598.3 Sequence, structure and vacuum electrostatics of E.coli DPS. A, The full 
E.coli DPS sequence and residues un-resolved in the structure (red). B, The DPS 
monomer (PDB id: 1F30) . C, The DPS dodecamer complex with the flexible N-
terminal exposed to the surface. D, The vacuum electrostatic model representing, 
negative (red),neutral (white) and positive (blue) from the remaining N-terminal. 
 
8.8 Elucidating the DPS:DNA crystal complex and neighbouring dodecamer 
contacts 
 
The structure of DPS has been determined through X-ray crystallography methods 
for E.coli and a range of prokaryotic organism figures as illustrated in Figure 8.2. At 
present there is no structure which shows the DNA interaction region of DPS, since 
the N-terminal residues are non-visible in all DNA binding structures.  
A high resolution DNA protein complex is a worthy pursuit to prove that DNA 
interactions are mediated by lysine and Mg2+ bridging as suggested in the literature 
[169,186]. The study showing that the lysines confer the DNA interaction and self-
aggregation did so by either removing the first 8 or 18 amino acids which also 
exclude other potentially important residues under the assumption that they had 
no affect to binding.  
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In conjunction with obtaining a structure of the DPS:DNA complex this study will 
also assess the interactions to neighbouring E.coli DPS dodecamers to assess 
whether these residues can make direct polar interactions with neighbouring 
dodecamers within the crystal structure. Interestingly other non-DNA binding 
species of DPS also adopt the hexagonal crystal packing to imply that DPS self-
aggregation may not be entirely mediated by DNA binding. Therefore, through 
comparing the structures of the most conserved DPS species to E.coli  (Figure 8.1) it 
is possible to search for conserved inter-protein interactions and to determine 
whether polar contacts could have any significance during self-aggregation.  
These goals may be of interest to develop targets suitable to disrupt the 
effectiveness of bacterial stress responses to enhance current bacterial infections 
that tend to be growing in resistance on a seemingly yearly basis. DPS has already 
been shown to confer resistance to bacterial treatments and has been considered 
as a drug target [187]. Given the similarities between DPS sequences and structure 
in prokaryotes, these drugs could have the potential to treat a wide variety of 
bacterial infection. Disrupting just one function of DPS should make organisms 
more susceptible to new or old treatments e.g. penicillin. 
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Chapter IX 
Expression, purification and preliminary analysis of 
DPS structure 
9.1 Over-expression of DPS 
 
To over-express DPS two different plasmids were constructed one containing an N-
terminal 6xHis tag and one without any additional residues. The 6xHIS DPS 
construct contained an extra 2.2 kDa incorporating the sequence 
MAHHHHHHSSGLEVLFQ*GP with a 3C protease cleavage site that could cleave after 
glutamine illustrated by (*). The rationale to include this tag was to reduce the 
number of chromatography steps during purification and since the tag was 
relatively small it wasn’t anticipated to disrupt the DPS dodecamer assembly. 
Alongside this construct a plasmid containing untagged DPS was also made to 
produce protein identical to that described by Almiron in 1992 [161]. 
The main difference between the Almiron procedure and this study was the type of 
vector used to over-express DPS in E.coli. Almiron used a plasmid adapted to 
control DPS expression by stress related Sigma factors which activate during 
nutrient deprivation during early stationary-phase. As DPS is only normally 
expressed under stress in prokaryotes the advantage is DPS is less likely to be 
removed by bacterial degradation machinery. During Almirons’ protocol E. coli was 
shown to over-express DPS in abundance when the bacteria entered the 
exponential stage of its growth cycle [161].  
During this study protein expression for both DPS plasmids were under the control 
of the lac operon active in the presence of IPTG as used previously for TDP-43S, 
chapter III. This methodology aimed to reduce the total time required to over-
express DPS, since starvation was not required, however complications could arise 
from expressing DPS during an irregular period in the E.coli life-cycle.  Therefore an 
important preliminary experiment was to first establish whether IPTG could induce 
detectable amounts of DPS and whether this was soluble. 
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9.2 IPTG concentration and incubation time 
 
IPTG was utilised to induce expression of both DPS constructs during the study 
using different concentrations (0.1-2.0 mM) and IPTG incubation times (3h,5h & 
overnight) initially on the N-terminally 6xHIS tagged DPS construct to probe the 
minimal levels required to detect DPS over-expression and accumulation of 
inclusion-bodies [188](Figure 9.1). DPS could over-express in all IPTG concentrations 
between the 15-20 kDa markers on an SDS-PAGE verified by an in-gel trypsin digest 
and fingerprint using MALDI-TOF mass spectrometry (Figure 9.2). The untagged 
construct also over-expressed using a low IPTG concentration (0.4 mM) over a 
relatively short time (5h) to provide two options for DPS overexpression and 
purification (Figure 9.1, B).  
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Figure609.1 DPS over-expression under different IPTG concentrations and 
incubation times. A, N-terminally HIS tagged DPS was induced using a variable IPTG 
concentrations and time. All conditions lead to over-production of DPS. B, The 
untagged DPS construct also over-expressed  (indicated by red arrow) when 
induced with 0.4 mM IPTG and a 5 hour incubation period.  
A 
B 
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Figure619.2 MALDI-TOF mass spectrometry of DPS trypsin fingerprint taken from 
12% SDS PAGE. N-terminal 6xHis tagged DPS (18.7 kDa) was identified by 
comparing against the peptide fragments expected from a theoretical trypsin digest 
of its sequence (inset). 
 
9.3 Solubility of N-terminal HIS tagged DPS 
 
Despite the confirmation that DPS could over-express it was uncertain whether 
these constructs were soluble in solution. To this end the lower IPTG 
concentrations were repeated but separated into soluble and insoluble fractions by 
centrifugal force (90 minutes, 47.7xg).  
Unfortunately the 6xHIS tagged construct expressed in the insoluble fraction 
despite inducing with low levels of IPTG and varying incubation times (Figure 9.3). 
This suggested that 6xHIS tagged DPS was prone to form inclusion bodies during 
expression which wasn’t expected compared to other studies [189].   
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Figure629.3 Solubility of 6xHIS tagged DPS. Tagged DPS cultures were split into A, 
soluble fraction and B, insoluble (lower gel) fractions by sonication and 
centrifugation at 19,000 rpm. The pellet containing insoluble proteins show that a 
large proportion of tagged DPS is being expressed between 15 kDa and 20 kDa to 
suggest DPS may be expressing as inclusion bodies. The soluble sample was dilute 
but DPS should still resolve considering that it was the most abundant protein and 
other bands can be seen.  
 
 
 
Given the quantity of over-expression a refolding protocol was employed adapted 
from the Terzic et. al. 2010 methodology [190] in an attempt to rescue the protein. 
This protocol had previously been used successfully to purify large octomeric 
complexes of the nucleotide binding domains of sulfonylurea receptors (SURA). 
Though the protocol re-solubilised 6xHIS tagged DPS it failed to bind to a nickel 
affinity column and ssDNA cellose column described in Almirons 1992 protocol 
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[161] despite the tag being intact as shown through a western blot (Figure 9.4). This 
suggested that DPS was not refolding correctly and could not be used.  
 
Western Blot 
 
 
Figure639.4 Insoluble pellet wash and 6xHIS tag specific western blot for tagged 
DPS. construct. The pellet was washed in 1%Triton X-100 3 times (1-3) and then 
again in the same buffer without Triton X-100 which contained 50 Mm Tris, 50 mM 
NaCl, 1 mM TCEP, 0.5 mM EDTA and 5% glycerol pH 8.0 (4). The remaining insoluble 
pellet contained the remaining 6xHIS DPS and an intact N-terminal 6xHIS tag as 
shown in the Western blot. 
 
 
9.4 Production of untagged DPS 
Fortunately untagged DPS expressed in the soluble fraction under similar conditions 
to the 6xHIS tagged version (IPTG 4mM, 5h). This suggests that tagging of the DPS 
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N-terminal is disruptive to the structure during expression. The purification then 
followed the original protocol developed by Almirion et. al 1992.  
 
During the 30%, 60% and 90% ammonium sulphate (AS) cuts DPS was found in the 
60% and 90% fractions as described by the original authors with four fold more DPS 
precipitating in the 60% AS sample. The gel filtration was performed using pre-
packed gel filtration columns with high resolution ranges since DPS is prone to self-
aggregation, shown to elute near the void volume using a Superdex 200 16/60 
(Appendix 10).  A  Sephracryl 300 16/60 column was sufficient to separate DPS to 
elute the protein at ~55 ml in buffer containing 2M NaCl to dissociate the DNA 
(Figure 9.5). The fractions were pooled and returned into its original buffer by 
dialysis to produce >70% pure DPS (Figure 9.6).  Unfortunately the 2M NaCl wash 
wasn’t sufficient in removing all the DNA contaminant as judged through comparing 
the 260:280 nm wavelength ratios as previously described for TDP-43S, Chapter III. 
Through scanning the DPS spectra it was clear that there were differences between 
the DNA content of 60% and 90% AS cuts (Appendix 7) with 260:280 nm of 1.57 and 
1.01 respectively, indicating more DNA in the 60% fraction. DNA was present in 
both cuts indicative of a high absorption at 260nm (Appendix 7) so were 
independently screened by crystal trials in an attempt to obtain DPS:DNA 
complexes to determine the specific binding contacts that nteract with DNA and 
surrounding dodecamers.  The DPS peaks eluted between the 56-62ml elution 
volume and pooled as shown (Figure 9.5). 
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Figure649.5 Gel filtration profiles of 60 and 90% ammonium sulphate cuts. The AS 
fractions were purified individually down a Sephracryl 300 16/60 gel filtration 
column at 0.5ml/min-1 where DPS eluted at ~55ml. A, The elution profile of the 60% 
AS fraction and B, the 90% AS elution profile. The latter shows a better resolution of 
DPS to allow more volume to be pooled (shown in grey) for subsequent dialysis, 
concentrating and crystal trials. 
Sephacryl 300 16/60  
AS 90% untagged DPS  
B 
Fractions 
AS 60% untagged DPS  A 
C 
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Figure659.6 DPS purity after Size exclusion chromatography. The purity of the DPS 
used in determining the crystal structure after 2 gel filtration runs. This shows (Lane 
1) purity after 90% ammonium sulphate precipitation. Lanes 2-4 show the peak 
fractions from the AS 90% DPS fraction using the Sephacryl 300 10 30 column 
(Figure 9.5). Lane 5 Shows the final purity of DPS used in the successful protein 
crystallography of DPS after Superdex 200 10 60 purification.    
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Chapter X 
X-ray Crystallography study of E.coli DPS 
 
Purified DPS crystallised and analysed by X-ray crystallography. This is a standard 
method in determining protein structure used to extract atomic co-ordinates from 
protein crystals. There is a large list of X-ray crystallography literature available to 
describe the technique in detail [191–193], however the following sections will 
provide the brief methodology used in context of the DPS project.   
10.1 X-ray crystallography 
 
X-ray crystallography (PX) is well suited for the study of DPS since the complex 
readily forms ordered crystals. PX works by determining the electron density 
contained within a single asymmetric units (unit cell) that is self-repeated 
throughout the structure of the crystal. This self-propagating unit cell acts to 
amplify X-ray diffraction signal that would otherwise be too weak to determine the 
parameters necessary to solve the macromolecular structure. The detected 
diffraction is measured in reciprocal space with co-ordinates h, k, l and this relates 
inversely to the electron density of the unit cell with co-ordinates x, y, z  (Figure 
10.1) by the following relationship;  
 (     )  
 
 
∑∑∑|    | 
    (              )
   
 
Equation (10.1) 
 
Where      is the structure factor describing the contribution of scatterers to 
reciprocal reflections,   is the imaginary number (-1)1/2, ‘    and    are the 
reciprocal coordinates of the real space and   describes the phase. The phase is the 
only parameter that cannot be measured or determined from the reflection pattern 
or X-ray source, which as noted in equation 10.1 is a prerequisite for solving the 
electron density of the unit cell (Equation 10.1) [194]. During this study the phase 
was obtained by molecular replacement using a previously solved structure though 
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other methods including isomorphous replacement and anomalous diffraction can 
also be performed [194].  
 
 
 
Figure6610.1 Cystallographic data collection. The real space co-ordinates (x,y,z) 
relate to the reflections measured in the reciprocal space by an inverse relationship 
(equation 10.1). The furthest reflections measured describe the closest distances in 
real-space related to the maximum resolution that can be described by the data. 
The crystal needs to be rotated in order to record all reflections corresponding to 
the electron density in order to build the 3D structure.  
 
10.2 Data manipulation 
 
The first step is concerned with understanding the unit cell and quality of the data. 
Because a crystal and unit cell conformation is static in one arrangement an angular 
range probing different crystal orientations is required during data collection to 
provide diffraction of the 3D co-ordinates. Therefore a crystal dataset can consist of 
many diffraction images. Through time and rotating the crystal the intensities even 
for the same reflections can differ between images due to different crystal lengths 
or beam-fluctuations. Firstly the data is reduced performed by indexing the 
125 
 
reflections to their respective h, k, l co-ordinates. From these Miller indices the cell 
type, dimensions, mosaicity, Intensity (    ) and uncertainty (  ) can be derived 
which are performed by the programs iMOSFILM [195] or HKL2000 [196]. To 
normalise the intensities of each reflection the h, k, l co-ordinates are compared 
against multiple frames to assign relative      values performed by SCALA [197] or 
HKL2000. Data collection quality is commonly assessed by the Rsymm value as 
described in Equation 10.2. 
 
RSymm 
Rsymm is a quality measure for the collected data which compares the extent each 
unique reflection deviates from being equal to each other commonly shown as a 
percentage.   
 
  
∑ ∑ |  (   )   (   )  |    
∑ ∑ (   )    
 
(Equation 10.2) 
 
Where    is the intensity of a single reflection. 
 
10.3 Phasing by ‘Molecular Replacement’ 
 
As mentioned previously the phases of the reflections are a prerequisite to solving 
the structure which cannot be measured directly from the diffraction images. This is 
because      is a wave function and as such must include information regarding 
amplitude, frequency and phase. The former two functions are known from the 
experiment; the frequency is the same as the X-ray source and amplitude is related 
to the      which is related to the intensities of all reflections. The most efficient 
method of obtaining phases is to substitute them from a similar crystallographic 
structure. Through combining the experimental indexed co-ordinates and phases 
from a similar structure the diffraction data containing all wave functions can be 
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solved using algorithms in the MOLREP [198] software to generate a rough guide of 
electron distribution. 
 
10.4 Refinement. 
 
The structure from molecular replacement using the experimental      is still a draft 
map of the electron density derived indicative of the discrepancies between the 
actual and the phases used. The draft map can be improved upon by adding 
residues or explaining unknown density of the model by adding/ rotating amino 
acids (known from the sequence) or adding structure of known buffer components.  
This refinement aims to lower the R values that measure the accuracy of the model 
to the data (Equations 10.3). Gradually filling the unknown density by this method 
gradually improves the model to resemble the real space co-ordinates of the 
protein judged through improved statistics.  
During this study non-crystallographic symmetry was applied and the data was 
refined using rigid-body refinement to a single monomer of E.coli DPS structure 
(PDB id: 1F30). 
Models were built using COOT [199] and refined by REFMAC [200].    See below on 
how the R-values and important statistics are used in interpreting the model 
quality; 
R-factor 
  
∑||    |  |     ||
∑|    |
 
 
(Equation 10.3) 
     is the structure factor amplitude from the native dataset and       is the 
structure factor calculated from the model. 
R-free 
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R-free measures how well the current atomic model fits with a random subset of 
measured intensities not used during refinement which is less biased then R-factor. 
Sigma I (σ(I)) 
Mean intensity divided by the error, a measure of 1 implies that only background 
has been measured. The Sigma cut-off was set at 0.00, meaning that intensities 
which have a negative value on the detector were ignored. 
B-factor 
Otherwise known as the temperature factor. This is a measure of the oscillation 
around a position specified in the model that naturally occurs in protein structure.  
Since diffraction can be affected it is appropriate to assign a value to the positional 
variation of atoms in the model.  
 
 
 
 
 
 
 
 
 
 
 
 
 
128 
 
Chapter XI 
 
DPS structure and polar contacts involved in crystal 
formation 
 
11.1 DPS crystallisation 
 
The DPS crystallisation trails uncovered a variety of suitable conditions for DPS 
crystallisation however only a few of these conditions produced crystals large 
enough (typically > 0.1mm at its longest dimension [201]) for PX analysis. The 
largest crystals were taken to the Diamond synchrotron source in Oxford to 
maximise the diffraction and intensity profile. The DPS crystals that diffracted were 
grown from the 90% ammonium sulphate cut obtained from a 1:1 ratio containing 
4mg/ml DPS and 0.2M NaNO2, 20% w/v PEG 3350.  
The resolution was limited to 2.74 Å which is comparable to previously solved DPS 
structures, including E.coli (PDB id: 1F30). The data collection statistics and 
parameters for the E.coli DPS structure are shown in table 11.1. Waters were 
absent during rigid-body refinement, using isotropic B-factors and non-
crystallography symmetry to a single monomeric unit (residues 1-167) of E.coli DPS 
(PDB id:1F30).  Unfortunately DNA was absent in this crystal structure as observed 
in other DPS complexes solved so far. The N-terminal regions of DPS monomers 
were also missing. The last N-terminal residue visible in the electron density was 
Thr12. The fact that the remaining N-terminal residues are missing and known to be 
bound by DNA supports the notion as in other DPS structures that DNA and N-
terminal residues are flexible within the hexagonal crystal packing.      
11.2 DPS unit cell 
 
The P1 asymmetric unit cell contained three full DPS dodecamers, with maximum 
unit cell dimensions of 222.95 Å (Figure 11.1). The proteins positioning within this 
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cell shows that the orientation between individual DPS dodecamers differs. This is 
to presumably enhance the positions of functionally important residues important 
to bind DNA and neighbouring DPS, to form the large crystalline DNA containing 
structures observed in vivo during bacterial stress responses [170]. Interestingly the 
rotation of each neighbouring DPS complex differed by a ~120˚ rotation at a ~45˚ 
tangent axis to each neighbouring complex mimicking the three-fold symmetry of 
the ferritin-like pores that coincidently align close to the gaps generated between 
dodecamers. This packing is tight between neighbouring complexes showing that 
the DPS assemblies interact. The positive charge is caused by the remaining N-
terminal which protrudes next to dodecamer binding sites. The majority of the 
complex is neutral apart from the ferritin-like channels that are negative.  
Table411.1 DPS crystal structure statistics 
 
Data collection and parameters E.coli DPS (During this project) 
Wavelength (Å) 0.98 
Space Group  P1 
Dimensions (Å, ˚) a= 86.95, b=90.18, c=222.95   
α=80.40, β=86.69, γ=61.44 
Resolution (Å) 2.74 
Observed Reflections 
Number of atoms used during 
refinement (non-hydrogen) 
134843 
 
44496 
Redundancy 3.0 (2.6) 
Completeness (%) 92.20 (52.44) 
Rsymm (%) 28.77 (40.70) 
I/σ(I) 17.78 (4.59) 
Resolution range 30.00-276 
R-factor/R-free (%) 28.77/32.87 
Bond length (Å) 0.011 
Bond Angle (˚) 1.292 
Average B-factor (Å2) 60.97 
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Figure6711.1  E.coli DPS unit cell packing, complex charge and orientation. The unit 
cell of DPS. A, Showing the dimensions of DPS cell and monomer orientation within. 
Three complexes form within the P1 space group. B, The vacuum electrostatics 
(PyMol http://pymol.com/) show the distribution of charge and orientation to 
neighbouring complexes. Note that the N-terminal is positive (blue), the surface of 
the complex is neutral (white) except for ferritin-like iron channels (red).  
 
11.3 DPS-DPS interactions 
 
From the crystal structure (analysed in PyMol) the central DPS dodecamer forms 
three polar interactions to each neighbour in the same plane and two to a single 
DPS dodecamer in the plane behind (Figure 11.2). In the longest dimension (z axis) 
polar interactions can occur between residues N99, S106, K134 to D20, T12 and 
N99 respectively. The contacts involve two monomeric subunits from each complex 
and interestingly involve Thr12 to suggest that this residue may be important in 
organising the self-aggregation when DNA is bound in E.coli DPS.  This residues 
involvement in forming this contact likely explains why it can be resolved by 
crystallography despite its position on an unstructured region of the protein.  
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The hexagonal packing arrangement means that dodecamers form a cleft involving 
three other dodecamers (Figure 11.2). However interactions only form to two of 
these using two polar interactions; R18, D20 to S100 and T12 respectively meaning 
these interactions are likely weaker than the neighbours separated about a 120˚ 
angle (Figure 11.2, C & D). This is representative of the DPS layers described by Wolf 
in E.coli during crystallisation [170], suggested to be important during DNA packing.  
The weaker interaction to dodecamers on this plane means that DPS form a gap 
(Figure 11.3). The N-terminals of surrounding dodecamers are positioned to face 
this space. Because only two polar contacts form to just one of these dodecamers 
more space is generated which may be important to localise the remaining 33 
missing residues from each dodecamer and the condensed DNA (Figure 11.3).  
 
Figure6811.2 Polar contacts between neighbouring E.coli DPS complexes’. The polar 
contacts formed between the central DPS dodecamer in the unit cell. A, The DPS 
cartoon representation of the monomer organisation, neighbour contacts and 
electrostatic potentials. The polar contacts formed between B, the left  dodecamer 
and C, the right dodecamer. Stars (*) indicate contacts are mediated on the same 
monomer. 
132 
 
 
 
 
Figure6911.3 E.coli DPS complex packing and suspected DNA containing cleft. The 
DPS hexgonal arrangement. A, The hexagonal layers arrangement. B,  The top view 
of this packing assembly, in the blown up image below you can observe the 
elongated cleft generated between interacting dodecamers.   
 
 
11.4 DPS structure comparisons 
 
Through comparing the DPS monomeric subunits from different species there was 
little observed differences between the structural alignment and RMSD values 
(Figure 11.4 & Table 11.2). The largest differences were from the remaining N-
terminals which were anticipated given that this region lacks secondary structure 
and is likely to be flexible. The lowest RMSD is unsurprisingly from E.coli at 0.14 Å 
and the largest is from M. smegmatis at 0.73 Å which is due to its elongated C-
terminal which extends nine residues further than E.coli in the structure and twenty 
seven in sequence.   
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Figure7011.4 Alignment of E.coli DPS with previously solved DPS monomers. The 
superimposition of the monomeric DPS structure between different species. A, DPS 
in this study was compared against species with known structures (shown in red). 
To include B, Myobacterium smegmatis PDB Id: 1VEI.  C, Yersinia pestis PDB Id: 
4DYU . D, Escherichia coli PDB Id: 1F30. E, Salmonella enterica PDB Id: 3AK8. F, 
Brucella melitensis PDB Id: 3GE4 and G, Agrobacterium tumefaciens PDB Id: 1O9R.  
Table511.2 The structural conservation between DPS monomers. 
DPS Structure (Residues) No. atoms 
used IN 
RMSD 
RMSD to 2.8Å DPS 
structure * 
Model No. 
M. smegmatis (1-175) 125-125 0.73 B 
Y. pestis (13-166) 149-149 0.34 C 
E.coli  (12-166) 142-142 0.14 D 
S. enterica (14-166) 146-146 0.24 E 
B. melitasis (6-166) 128-128 0.47 F 
A. tumefaciens (1-162) 133-133 0.52 G 
* Note that RMSD values may differ due to crystal structure resolution and are 
shown here as a rough guide to DPS similarity 
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11.5 DPS packing similarities between other species 
 
The hexagonal packing from this study is consistent with that of other species 
(Figure 11.5). The packing of M. smegmatis DPS which binds DNA through its C-
terminal domain can also adopt both cubic and a hexagonal cells [202](not shown) 
to suggest that DNA binding may not be the only determinant in crystal packing and 
self-aggregation.   
 
  
Figure7111.5 The organisation of complex assembles of DPS crystals between 
species. The unit cells of DPS crystal complexes were compared to show packing 
differences, unit cell parameters and charge. The crystals are from A, 
Myobacterium smegmatis PDB Id: 1VEI. B, Yersinia pestis PDB Id: 4DYU . C, 
Escherichia coli PDB Id: 1F30. D, Salmonella enterica PDB Id: 3AK8. E, Brucella 
melitensis PDB Id: 3GE4 and F, Agrobacterium tumefaciens PDB Id: 1O9R. 
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Except for M. smegmatis the DNA binding species with conserved N-terminal 
lysines in E.coli [161], Y. pestis, and S. enterica all crystallised with the largest unit 
cells. This suggests that being bound to DNA does have some effect on the 
hexagonal crystal packing arrangement. Using the non-DNA binding species of A. 
tumefaciens as a comparison, the hexagonal arrangement is more uniform to reveal 
just one conformation of the DPS dodecamer mediated by 3 polar contacts to 
dodecamers on different planes (Figure 11.6). In the packing of E.coli DPS these 
neighbouring contacts are variable which may be an adaptation to optimise the 
amount of DNA which can be stored, facilitated by the ability of DPS to form 
multiple polar interactions when rotated (Figure 8.1). Though DNA binding has been 
shown as critical for self-assembly it is likely that when DPS dodecamers come into 
contact with DNA the polar interactions may further stabilise its positioning.    
   
 
Figure7211.6 Non-DNA binding model of A.tumefaciens hexagonal crystal packing. 
The small unit cell is indicative of a simple DPS organisation which is mediated by 3 
polar contacts at each corner of the dodecamer and none with the DPS above and 
below on the same plane. Stars (*) indicate contacts are mediated on the same 
monomer. Using PDB model; 1O9R. 
11.6 Polar anchors.  
 
Polar interactions were observed in every DPS crystal. Since the sequence identities 
between E.coli and the DNA binding species; Y. pestis and S.enterica were well 
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conserved (80-95% identical, expasy BLAST) it was thought that perhaps these polar 
contacts may also be maintained to describe a common self-assembly mechanism 
involving polar interactions. Using the polar contacts of E.coli observed during this 
study, 3/7 residues involved also formed interactions in either of these two species. 
Using the numbering of E.coli conserved residues involved in these interactions 
were Asp99, Ser106 in Y.pestis and Arg18 in S.enterica.  To suggest that polar 
contacts can vary during self-aggregation.  
There is a high level of conserved charged surface residues accessible in DPS 
throughout all DPS species (Figure 8.1) capable of forming polar contacts (Table 
11.3). Given this and the fact that the surface of DPS does not mediate any 
identified interaction with DNA suggests that perhaps the function of these 
residues is to form stable interactions which can form using a combination of 
residues depending on the amount of DNA.  
Table611.3 Residues involved in forming polar contacts between DPS dodecamers 
DPS species Residues involved in forming contacts 
DNA-Binding Species (Numbering as ClustalOmega 
alignment)  
E.coli  
(E.coli from 1F30) 
T15, R21, D23, N102, S103, S109, K137,  
(T12, D23, D26, S25, L17, D26, K146) 
Y.pestis  H27, N102, S109, E146, L107 
S.enterica R21, S27, D28, D119, K122, E173  
M. smegmatis K103, D108 
Non-DNA binding species  
A.tumefaciens N27, K116, D122, D140, E144, S176  
B. melitensis S26, K108, D119, E126, D130, N176  
 
11.7 Significance of polar contacts and DNA in DPS packing  
 
The crystal structure of the E.coli DPS:DNA complex could not be resolved despite a 
strong indication that it is DNA bound. This confirms as with other DPS structures 
that at least the first 11 residues are flexible in this structure. It is likely that DNA is 
contained within the cleft generated between layers of weaker contact as this was 
shown to generate a larger pore and is the most likely place for DNA to be stored as 
previously suggested by Grant et. al 1998 [185].  
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The hexagonal packing is observed in all DPS species however the larger unit cells 
are associated with the DNA-binding species.  Since many of the polar residues 
responsible in forming interactions with neighbouring dodecamers are largely 
conserved there is no other reason why this packing should change other than the 
addition of DNA.  Through comparing the hexagonal packing arrangements 
between DNA and non-DNA binding species we observe that dodecamers rotate 
120˚ which allows them to come into closer contact when compared against a non-
binding species. This is likely to mimic the three-fold symmetry of the ferritin-like 
pores and to orient N-terminal residues into the clefts between dodecamers. This 
would allow the N-terminals to interact to possibly the same condensed DNA and 
convey the very stable aggregates described by Almirion et. al. 1992 [161]. This 
would also explain why the longer unit cell dimensions are also observed within 
DNA-binding species.  
The actual polar contacts observed in the structure are poorly conserved, even in 
the same species as shown between the E.coli in this study and previously solved 
structures (PDB id; 1F30, 1DPS). This implies that the positioning of DPS within the 
crystal and possibly the in vivo aggregates are not mediated by specific polar 
interactions. However given the large amount of polar residues accessible on the 
dodecamer surface which is made equally from negative and positive residues 
(Figure 8.1) not involved in DNA binding or ferritin-like activity [169,176], it is 
possible that they provide points of contact that aid to stabilise the dodecamer 
assembly. This may also explain why DPS is readily crystallisable in a variety of 
species. 
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Chapter XII 
Materials and methods   
 
12.1 Generating the wild-type TDP-43S plasmid 
 
The ‘mTDP-43SpGEX3X’ plasmid components were generated by amplification of 
residues 101-265 of Mouse TDP-43 DNA (GI: 156616305) and additional base pairs 
incorporating the 3’ BAMHI and 5’ AatII restriction enzyme sites (New England 
Biolabs (NEB)). This was performed by the polymerase chain reaction (PCR) utilising 
the ‘pGEX3XmTDP-43SFwd’ and ‘pGEX3XmTDP-43SRvs’ primers (Appendix 8) and 
KOD Hotstart DNA polymerase (Novagen) under the following cycling conditions; 
Table712.1 PCR cycling conditions used to amplify TDP-43S genes 
 
The amplified fragment was isolated by 1% TAE agorose gel electrophoresis set at a 
constant 100V and excised. The 513bp fragment was collected using the Wizard® SV 
gel and PCR clean-up system (Promega) and digested with restriction enzymes to 
generate the 5’ and 3’ sticky ends as described for the enzymes (NEB). The insert 
was ligated into a similarly treated linearized pGEX3X expression vector (GE 
Healthcare) using a 3:1 v/v insert/vector ratio as components in the reaction mix 
containing; 1x T4 ligase buffer, and 1µl T4 DNA ligase (NEB) in a 10µl total volume. 
This reaction was incubated at 16°C and left over-night.  
The reaction was transformed into competent Omnimax2 strain of E. coli cells 
(Appendix 3) and incubated on selective Luria Broth (LB) agar overnight at 37˚C. All 
  x30 
Cycles 
Stage          Temperature (°C)  Time (s) 
DNA Separation  95°C    60 
Denaturation  95°C    30 
Annealing  60°C    30 
Elongation  65°C    300 
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TDP-43S media selectivity was achieved through addition of 100µg/ml Ampicillin. 
Single colonies were grown in 5-10ml LB for >16 hours and isolated using Wizard® 
SV Miniprep DNA Purification system (Promega). The plasmid was sequenced 
verified using DNA terminator reaction techniques at GATC biotechnology using 
custom-made sequencing primers, ‘pGEX3X Sequence Rvs’ and ‘pGEX3X Sequence 
Fwd’ (Appendix 9). Purified plasmids were stored at -20˚C.  
 
12.2 Generation of D169G and K263E mutant TDP-43S plasmids 
 
Primers were designed to infer D169G and K263E protein mutations to create two 
separate mutant constructs (Appendix 1) from the ‘mTDP-43SpGEX3X’ plasmid. Site 
directed mutagenesis was performed using the QuikChange Lightning Site-Directed 
Mutagenesis Kit (Stratagene). The Primers; ‘MGD169GmTDP-43SFwd’, 
‘MGD169GmTDP-43SRvs’, ‘MGK263EmTDP-43SFwd’ and ‘MGK263EmTDP-43SRvs’ 
were designed respectively to substitute a bp to generate ‘D169GmTDP-
43SpGEX3x’ and ‘K263EmTDP-43SpGEX3X’ plasmids (Appendix 3). The mutated 
codon corresponding to the residue change is highlighted in Appendix 8.   
 
12.3 Expression of wild-type, K263E and D169G TDP-43S proteins 
 
All mTDP-43S and variant plasmids were transformed into E. coli BL21 DE3 
(Appendix 3) cells and plated as described previously for Omnimax2. Colonies were 
grown over-night using 1% of the desired growth volume in selective LB media. This 
overnight was then used to inoculate a larger growth volume (0.5-1L) and left at 
37°C in a shaking incubator set at 220 rpm, until an optical density measured at a 
600nm wavelength (OD600) of 0.5-0.8 was achieved.  Protein production was 
initialised by addition of 1mM Isopropyl β-D-1-thiogalactopyranoside (IPTG). 
Protein production was left for 5 hours at 30°C, shaking at 220 rpm, the cells were 
then pelleted at 3000g, at 4°C for 20 minutes. Pellets were flash frozen and stored 
at -20˚C.  
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12.4 Mouse TDP-43S purification 
 
TDP-43S was purified from the frozen -20˚C pellets which were thawed and 
resuspended in 1:3 w/v ratio of TDP-43S buffer (50 mM Tris-HCl, 150 mM NaCl and 
2 mM CaCl2 and pH 7.4), 0.2mg/ml lysozyme, 10µg/ml DNase and 10x concentrate 
protease inhibitor cocktail set III (Calbiochem).  Cells were lysed by sonication and 
cell debris removed by centrifugation at 30,000g for 90 minutes, TDP-43S proteins 
were contained in the soluble fraction. This fraction was filtered through a 0.2µm 
syringe filter (Milipore) and applied to an equilibrated GSTrapFF affinity 
chromatography column in the same buffer (GE Healthcare). The TDP-43S sample 
flow was set at 1ml/min-1 and ran through twice. The GST-TDP-43S bound GSTrapFF 
column was washed with 10 column volumes of high salt (0.5M NaCl) TDP-43S 
buffer, to remove electrostatic interactions. The GST column was then returned 
into standard TDP-43S buffer.  
The GST tag was removed on column using Factor Xa as described in the GSTrapFF 
manual (GE Healthcare). To elute and remove proteases the sample was passed 
through an attached BenzamidineFF column (GE Healthcare) and 95% pure TDP-43S 
was collected. Concentrated TDP-43S proteins were further purified to 99% by 
passing down a pre-equilibrated Superdex 200  16/60 (GE Healthcare)  gel filtration 
column in TDP-43S buffer at 0.8ml/min-1. TDP-43S eluted between 92-96ml.   
 
12.5 Calibration of Superdex 200 16/60 gel filtration column  
 
Molecular weight standards were calibrated to the elution volume of a Superdex 
200 16/60 gel filtration chromatography column using the ÄKTA purifier system (GE 
Healthcare).  The standards include; BSA (67 kDa), myoglobin (17 kDa) (Sigma) and 
SOD1 dimer (32 kDa) (UoL) which were individually ran at 2mg/ml concentration 
and 2.5ml sample volume.    
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12.6 Mouse TDP-43S crystallisation trials 
 
Concentrated Mouse TDP-43S protein (5-10mg/ml) were screened using hanging or 
sitting drop vapour diffusion methods. The hanging drop used pre-greased hanging-
drop plates and cover slips (Hampton Research) whilst the sitting drops were set in 
96 well sitting plates, and covered using clear sealing film (Hampton). Drops were 
mixed in a with reservoir solution in either a 1:1 or 2:1 ratio as described in Chapter 
III.  The plates were sealed and incubated at 4°C or 18˚C and observed weekly using 
a light microscope.  The list of trials used are included in ‘Chapter III, Table 3.2’. 
 
12.7 Differential scanning fluorimetry melting temperature assay 
 
DSF was performed using specific 96 well MicroAmp® plates (Life technologies) in a 
60µl volume with 10x Sypro-orange (Life technologies) and TDP-43S variants at a 
concentration of 0.6 mg/ml, repeated seven times for each. Samples were 
measured using a real-time PCR thermal cycler (StepOnePlus Applied Biosystems) 
covering the temperature range 14-95°C, increasing at a rate of 1.2 °C/min-1. 
Fluorescence was measured at ~470 and ~610 nm for excitation and emission 
respectively. The 7 melt curves for each; wild-type, K263E and D169G constructs 
were obtained and averaged and their first derivative plotted and analysed to 
obtain their respective melting temperatures. 
 
12.8 Unfolding tracking by aromatic fluorescence 
 
Aromatic fluorescence of TDP-43S samples (0.45mg/ml) were monitored in a 
fluorimeter using excitation and emission wavelengths of 280 and 340 nm 
respectively. A total of 6 repeats for each construct and buffer were performed. 
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Samples and buffer were preheated for 5 minutes over 2 °C increments between 37 
to 65°C. The samples were buffer subtracted and averaged to produce the data 
points and standard deviations. Boltzmann curve fitting was calculated using Origin 
8.6 (OriginLab). 
12.9 Small angle X-ray solution scattering data collection 
 
The small angle X-ray solution scattering (SAXS) data for TDP-43S and variants were 
collected at St Aubin, France using the Soleil, synchrotron facility and their 
dedicated SAXS station, SWING [106]. X-ray wavelengths were set at 1.03 Å and the 
CCD sample detector (AVIEX 170x170mm) was positioned 180cm from the sample, 
covering the momentum transfer range (q) =0.01 - 0.57 Å-1, where q=4πsinθλ-1 (λ is 
the wavelength of the incident radiation and θ is half the angle between the 
incident and scattered radiation). The SWING beam-line was coupled to a Shodex 
KW402.5-4F HPLC system set at 25°C and equilibrated with TDP-43S buffer. A 40µl 
sample volume of concentrated TDP-43S (10mg/ml) was injected and its elution set 
at 300µl/min-1 flow was collected over 255 frames.  Each frame was measured for 
one second and separated by 0.5 second dead time. The buffer profile for 
subtraction was achieved through averaging 20 frames prior to the proteins elution.  
The data were integrated, averaged, buffer subtracted and reduced using the in-
built Foxtrot software developed in house at Soleil to generate 1D profiles of 
individual frames. 
12.10 SAXS data interpretation and modelling 
 
The 1D data selection was performed and averaged by PRIMUS [203] and radii of 
gyration (Rg) estimated to within qRg limits of <1.3.  The p(r) profile and Dmax were 
calculated with Gnom, which generated the input for ab inito modelling. The ab 
initio modelling software, GASBOR was used to generate TDP-43S bead models of 
the Cα trace. The default software parameters were ran to fit the entire curve, with 
no symmetry (P1) constraints. This was repeated 10 times for each construct and 
averaged to produce the average electron distribution, calculated by DAMAVER 
[133].   
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The rigid-body modelling using the experimental 1D curves was performed by 
BUNCH [115]. Rigid-bodies for mouse TDP-43S RRM1 and RRM2 were derived from 
the PDB ids; 2CQG and 3D2W respectively. DNA was removed and structures 
truncated to contain residues 106-177 and 193-259. The Cα trace for residues 101-
105, 178-192 and 260-265 were reconstituted using the online software SABBAC 
and copied into the PDB file. All 1D SAXS curves derived from ab initio and rigid-
body models were fitted against the original 1D SAXS curves by CRYSOL [117], 
goodness of fit assessed by  2 minimisation. All model visualisations and RMSD 
alignments were performed using PyMol (http://pymol.com/). 
 
12.11 TDP-43S heat mediated aggregation 
 
The radiusi of gyration was estimated  by the Guinier approximation using data 
collected in-house at the Barkla X-ray Laboratory of Biophysics at the University of 
Liverpool, at 20 and 40°C for each construct. TDP-43S samples (3mg/ml) static 
measurements performed in a mica cell in TDP-43S buffer with the addition of 
20mM DTT. Scattering were collected on a MAR300 image plate at a distance of 
1.25 m from the sample. Protein and buffer scattering were recorded over 3 
separate 20 minute exposures which were then averaged. Data integration and 
analysis were performed using Fit2D [204] and PRIMUS [203]. The bounds of the 
Guinier region (qRg) all lay below 1.3 for each construct except the wild-type at 
40°C which due to the large size was <2.0. 
 
12.12 Circular dichroism 
 
The optical activity of TDP-43S variants was determined at the Soleil synchrotron 
using the DISCO station [205]. Wild-type and mutant TDP-43S proteins were 
dialysed against 50mM phosphate buffer (pH 7.2) and 50mM NaF to a 0.8mg/ml 
final concentration.  Measurements were taken using a 0.02cm quartz cell and 9 
second acquisition time in range 180-260 nm. Data acquisition was repeated 3 
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times for each construct before buffer subtraction, averaging and smoothing by 
averaging two consecutive points. The data points were calibrated to CSA at a 
concentration of 6.3 mg/ml to correspond to peaks at -37.54 at 192.3nm and 18.13 
at 291.4nm. CDSSTR secondary structure prediction was performed using the 
DichroWeb On-line server, using the SP175 reference set [136]. 
 
 
  
12.13 E. coli DPS cloning 
 
The DPS gene was amplified directly from the genome of E. coli DE3 strain using 
primers designed for use with the in-fusion protocol (Clontech). Two DPS constructs 
were generated containing an N-terminal His tag amplified using ‘pOpinFE 
coliDPSFwd’ and ‘pOpinFE.coliDPSRvs’ or without using ‘pOpineGFPDPSFwd’ and 
‘pOpineGFPDPSRvs’ primers (Appendix 1). Amplification was performed as 
described for ‘mTDP-43SpGEX3X’ except for a reduction to 60˚C in the elongation 
temperature.  
PCR reactions were ran on 100V TAE gel corresponding to ~500bp which were, 
excised and extra contaminants removed (PCR clean-up system, Promega). The 
6xHis tagged insert was ligated into a double digested pOpinF plasmid performed 
with HINDIII and KpnI restriction enzymes (NEB). The untagged insert was ligated 
into a similarly treated pOpineGFP plasmid and both adhered to the In-fusion® HD 
cloning kit procedure (Clontech). The reaction was transformed into Omnimax2 
cells and incubated in selective agar plates overnight. The selectivity for DPS was 
achieved with 50µg/ml ampicillin. Colonies were grown overnight in 5-10ml 
selective LB broth, isolated, sequenced and stored as described for ‘mTDP-
43SpGEX3X’, using the ‘T7Minus1’ sequencing primer. 
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12.14 DPS expression 
 
Both DPS plasmids were transformed into DE3 E.coli cells and plated overnight on 
selective media (50µg/ml ampicillin). Colonies were grown over-night using 1% of 
the desired growth volume in selective LB media. This overnight was then used to 
inoculate a larger growth volume (0.5-1L) and left at 37°C in a shaking incubator set 
at 220 rpm, until an OD600 of 0.5-0.8 was achieved.  Protein production was 
initialised by addition of 1mM IPTG. Protein production was left for 5 hours at 18°C, 
shaking at 220 rpm, the cells were then pelleted at 3000g, at 4°C for 20 minutes. 
Pellets were flash frozen and stored at -20˚C.  
 
 
12.15 Purification of untagged DPS protein 
 
DPS was purified from the frozen -20˚C pellets thawed and resuspended in 1:3 w/v 
ratio of DPS buffer (50 mM Tris-HCl (Ph 8.0), 500 mM NaCl and 0.1 mM EDTA), 
0.2mg/ml lysozyme, 10µg/ml DNase and 10x concentrate protease inhibitor cocktail 
set III.  Cells were lysed by sonication and cell debris removed by centrifugation at 
30,000g for 90 minutes, untagged DPS was found in the soluble fraction and filtered 
through 0.2 µm pores. The least soluble proteins in this fraction were removed by 
30%, 60% and 90% ammonium sulphate (AS) precipitation. DPS was found within 
the 60 and 90% AS cuts. Cuts containing DPS were purified further using a sephacryl 
300 16/60 gel filtration column (GE healthcare) set at 0.5ml/min-1, equilibrated in 
DPS buffer containing 2M NaCl.   
12.16 Tagged DPS 
 
The purification of tagged DPS was performed as described for untagged DPS 
except proteins were found in the insoluble fraction.  The pellet was resuspended 
into 50 mM Tris–HCl (pH 8.0), 50 mM NaCl, 5 mM TCEP and incubated with 4.5% N-
lauroylsarcosine which resolubolised the pellet after 30 minutes. Remaining 
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aggregates were removed by filtering through a 0.45 µm filter and refolded by 
dialysis into 2 litres of 10 mM Tris–HCl (pH 8.0), 0.05 mM EDTA, 0.1 Mm TCEP and 
0.03% N-lauroylsarcosine at least 3 times. The sample was found in the void volume 
after gel filtration as described for both TDP-43S proteins and untagged DPS. The 
western blot analysis was performed as described [206] only using anti-6xHis-
peroxidase antibodies (Roche) to avoid the use of secondary antibody. 
 
12.17 Isothermal titration calorimetry 
 
ITC was carried out at 25 °C with an iTC200 Microcal calorimeter (GE Healthcare). 
The TDP-43S proteins were tested in TDP-43S buffer in cell concentrations of 
4.6µM, 2.0µM and 2.6µM respectfully for wtTDP-43S, k263eTDP-43S and 
d169gTDP-43S. Titrations consisted of 1 preinjection of 0.3µl and 18 
consecutive 1.2μl syringe injections of thymine guanine repeated ssDNA ((TG)8 
ssDNA) at 60µM (Invitrogen). The stirring speed was set at 1000 rpm, and injection 
intervals set 180s apart. Anomalous points were removed and single-site boltzmann 
curve fitting performed by the integrated Microcal ITC200 software and Origin8 
(OriginLabs).   
 
12.18 DPS crystal screening and model refinement 
 
Sitting drop vapour diffusion of gel filtrated and concentrated untagged DPS (3-6 
mg/ml) from 60 and 90% AS fractions were screened. DPS protein and reservoir 
were incubated in a 1:1 v/v ratio with a total of 288 conditions from the Morpheus 
(Molecular Dimensions), PACT (Qiagen) and NATRIX (Hampton Research) 
commercial screens at 20˚C. Crystals were observed in each screen for both the 60 
and 90% AS cuts. After two weeks crystals were large enough in PACT, with 
reservoir condition 53 (0.2M NaNO2, 20% w/v PEG 3350) for 90% AS cuts. Crystals 
were washed in 30% glycerol for cryoprotectant prior to crystal mounting and X-ray 
data collection. 
147 
 
Data collection was performed on the IO4 station  at the Diamond light source 
(http://www.diamond.ac.uk/Beamlines/Mx/I04.html), Oxford, at 100 K using a 
Pilatus 6M-F detector at a wavelength set at 0.98 Å. The data were integrated using 
iMOSFLM [195] and scaled by SCALA [197]. Phasing was performed by molecular 
replacement using the PDB id: 1F30 crystallographic DPS model of E.coli by PHASER 
[207]. Model building was performed by COOT [199] and refined with REFMAC 
[200] which built a reasonable model at 2.74 Å with parameters described in 
‘Chapter IX’.   
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Appendices 
Appendix 1 – Clustal X colour scheme 
Colour Residue at 
position 
Conservation Rules 
Blue A,I,L,M,F,W,V,C {+60%, WLVIMAFCHP} 
Red R,K {+60%,KR},{+80%, K,R,Q} 
Green N {+50%, N}, {+85%, N,Y} 
Green Q {+60%,KR},{+50%,QE},{+85%,Q,E,K,R} 
Green S,T {+60%, WLVIMAFCHP}, {+50%, TS}, {+85%,S,T} 
Pink C {100%, C} 
Magenta E {+60%,KR},{+50%,QE},{+85%,E,Q,D} 
Magenta D {+60%,KR}, {+85%, K,R,Q}, {+50%,ED} 
Orange G {+0%, G} 
Cyan H,Y {+60%, WLVIMAFCHP}, {+85%,W,Y,A,C,P,Q,F,H,I,L,M,V} 
Yellow P {+0%, P} 
Residues are conserved if subsequent alignments succeed the minimum % quoted 
in brackets for the described amino acid. Adapted from 
http://www.jalview.org/help/html/ colourSchemes/clustal.html.  
 
Appendix 2 – Bacterial strains 
Strain Source Details 
Omnimax2 (E. 
Coli) 
Invitrogen F´ {proAB+ lacIq lacZΔM15 Tn10(TetR) 
Δ(ccdAB)} mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 Δ(lacZYA-argF) U169 endA1 
recA1 supE44 thi-1 gyrA96 relA1 tonA panD 
BL21 DE3 (E. coli) Novagen F– ompT gal dcm lon hsdSB(rB
- mB
-) λ(DE3 
[lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) 
M10616 (E. coli) University of 
Liverpool - Gifted 
F- Δ(ara-leu)7697 [araD139]B/r Δ(codB-lacI)3 
galK16 galE15 λ- e14- mcrA0 relA1 
rpsL150(strR) spoT1 mcrB1 hsdR2(r-m+) 
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Appendix 3 – Cloning and expression plasmids 
Name Source Details Size 
(bp) 
Selective 
Resistance 
pGEX3X GE 
Healthcare 
N-terminal GFP tag 
Factor Xa cleavable 
4,952 Ampicillin 
pOPINF OPPF N-terminal HIS tag 
3C protease 
cleavable 
5,457 Ampicillin 
pOPINEGFP OPPF C-terminal GFP tag 
3C Protease 
cleavable 
6,265 Ampicillin 
mTDP-43SpGEX3X N/A Contains WT TDP-
43S DNA sequence  
5,158 Ampicillin 
K263EmTDP-
43SpGEX3X 
N/A Contains K263E 
TDP-43S mutation 
in DNA sequence 
5,158 Ampicillin 
D169GmTDP-
43SpGEX3X 
N/A Contains D169E 
TDP-43S mutation 
in DNA sequence 
5,158 Ampicillin 
Mtdp-43f 
popinEGFP 
N/A Contains the TDP-
43F DNA sequence 
5,605 Ampicillin 
e.coli DPS popin F N/A Contains the DPS 
gene for E. coli 
5,758 Ampicillin 
R. pickettii popin F N/A Contains the DPS 
gene for R. pickettii 
5,685 Ampicillin 
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Appendix 4 – TDP-43S Dmax assignment 
 
 
Wild-type TDP-43S P(r) Profiles and respective fits.  Dmax comparisons at 75.5 and 
85.5Å and their respective fits to the wild-type TDP-43S 1D profiles. Using points 1-
925 using a lower 75.5 Å Dmax does not converse with the 1D data. 
 
 
 
 
q (Å-1) 
q (Å-1) r (Å) 
r (Å) 
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Appendix 5 – DSF blank 
  
DSF Blank. DSF fluoresence of 10xSypro Orange in buffer without protein with 7 
repeats showing that the dye had no affect to signal when elevating the temperature.  
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Appendix 6 – TDP-43S and ss(TG)8 stoichiometry by gel filtration 
 
TDP-43S and ss(TG)8 stoichiometry by gel filtration. A, wtTDP-43S elution alone 
eluted at ~14 ml volume. B, Single stranded (TG)8 alone eluted at a similar position 
~14.5 ml of volume. C, The TDP-43S bound sample with excess (TG)8 eluted with 
two peaks. This shows that only one wtTDP-43S molecule can bind (TG)8.  
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Appendix 7 – Absorbance of DPS 60 and 90% AS cuts at different wavelengths 
 
Wavelength spectra of DPS 60 and 90% AS cuts.  The DPS samples were pooled, 
concentrated for crystal trials and diluted 1/20 for a spectrum to be tested. The 
AS60% shows a higher absorbance at 260nm then its 280nm which suggests nucleic 
acid contamination 
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Appendix 8 – Cloning plasmids 
Cloning Primers 
pGEX3XmTDP-
43SFwd 
5’ - GCG GAT CCT TCA GAA AAC ATC TGA CCT CAT AGT GTT – 
3’ 
pGEX3XmTDP-
43SRvs 
5’ - GAC GTC TTA ATT ATG CTT AGG TTC AGC ATT GGA TAT 
ATG CAC – 3’ 
MGD169GmTDP-
43SFwd 
5’ – TGTCACAACGACATATGATAGGTGGGCGATGGTGTGAC 
TGTAA – 3’ 
MGD169GmTDP-
43SRvs 
5’- 
TTACAGTCACACCATCGCCCACCTATCATATGTCGTTGTGACA – 
3’ 
MGK263EmTDP-
43SFwd 
5’ - ATCCAATGCTGAACCTGAGCATAATTAAGACGTCA – 3’ 
MGK263EmTDP-
43SRvs 
5’ - TGACGTCTTAATTATGCTCAGGTTCAGCATTGGAT - 3’ 
pOpinFE coliDPSFwd 5’– AGTTCTGTTTCAGGGCCCGATGAGTACCGCTAAATTAGT 
TAAATCAAAAGCGAC – 3’ 
pOpinFE.coliDPSRvs 5’ – ATGGTCTAGAAAGCTTTATTCGATGTTAGACTCGATAAAC 
CACAG – 3’ 
pOpineGFPDPSFwd 5’- 
AGGAGATATACCATGAGTACCGCTAAATTAGTTAAATCAAAA-3’ 
pOpineGFPDPSRvs 5’- CAGAACTTCCAGTTTTTATTCGATGTTAGACTCGATAAA 
CCACAG-3’ 
 Amino acids shown in red are the codons responsible for the mutant change. 
 
Appendix 9 – DNA sequencing primers 
Sequencing Primers 
pGEX3X Sequence Rvs 5’ – GACACGGAAATGTTGAATACTC – 3’ 
pGEX3X Sequence Fwd 5’ – GGAGCTGCATGTGTCAGAG – 3’ 
T7Minus1 5’ – AATACGACTCACTATAGGG – 3’ 
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Appendix 10 - Aggregation of AS60% DPS as shown through gel filtration 
 
 
DPS Aggregation of AS60% DPS as shown through gel filtration. The untagged DPS 
fractions ran on the superdex 200 (S200) 16/60 eluted near the maximum 
resolution limits of the column and with a substantial amount of protein 
contamination still remaining from the sample loaded (C). The same preparation 
was repeated on a sephacryl 300 column and was found to benefit from higher 
resolution and with the majority of protein contamination removed.    
 
 
 
Superdex 200 16/60  
Fractions 
AS60% untagged DPS  
A 
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